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    The re-growth of injured neurons in CNS (central nervous system) is largely 
inhibited by the non-permissive environment around, and indeed several growth 
inhibitors have been identified so far. My thesis is aimed to study structures, 
dynamics and protein-protein interactions, as well as protein-small molecule 
interactions for two CNS regeneration inhibitors: Nogo-A and EphA4 receptor.  
Intracellular Nogo-A protein level is believed to correlate with stroke, as well as 
other neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and 
Alzheimer’s disease. Thus, it is of great interest to understand the mechanism of how 
Nogo-A protein level is regulated in vivo. An E3 ubiquitin ligase WWP1 was 
identified to be a novel interacting partner for Nogo-A both in vitro and in vivo, and 
down-regulated Nogo-A protein level by initiating the ubiquitination of Nogo-A. By 
using CD, ITC, and NMR, we have further conducted extensive studies on all four 
WWP1 WW domains and their interactions with a Nogo-A peptide carrying the only 
PPxY motif. Moreover, the solution structure of the best-folded WW4 domain is 
determined, and the binding-perturbed residues were derived for both WW4 and 
Nogo-A (650-666) by NMR HSQC titrations. On the basis of the NMR data, the 
complex model is constructed by HADDOCK 2.0. This study provides rationales as 
well as a template for further design of molecules to intervene in the WWP1-Nogo-A 
interaction which may regulate the Nogo-A protein level by controlling its 
ubiquitination. 
    EphA4 was proved to play key roles in the inhibition of the regeneration of injured 
axons, synaptic plasticity, platelet aggregation, and so on. In addition, EphA4 has 
unique ability to bind all ephrins including 6 A-ephrins and 3 B-ephrins. Therefore, 
studies of EphA4 structure, dynamics, and its interaction with ephrin ligands and 
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small molecules will be critical in understanding mechanisms underlying the binding 
between Eph receptor and ephrin ligands as well as molecule design targeting disease-
involved Eph receptors. Both crystal and NMR structures of free EphA4 LBD were 
resolved, revealing the highly dynamic property of loops that comprising the classical 
binding pocket.  Dynamics study shows that the whole EphA4 ligand binding domain 
undergoes dramatic conformational exchanges on µs-ms time scales. These results 
may have crucial implications in understanding why EphA4 owns a unique ability to 
bind all 9 ephrins. The results with EphA4 dynamics may also help to design and 
optimize small molecule agonists and antagonists with high affinity and specificity for 
EphA4. The crystal structure of the EphA4-ephrin-B2 complex was also determined 
and an additional interaction surface was identified which will enhance the affinity 
and specificity of the interclass binding. These findings contribute to our 
understanding of the distinctive binding determinants that characterize selectivity 
versus promiscuity of Eph receptor-ephrin interactions and suggest that diverse 
strategies may be needed to design antagonists for effectively disrupting different 
Eph-ephrin complexes. The first two small molecules which antagonize ephrin-
induced effects on EphA4-expressing cells were also presented in our work. Their 
binding with EphA4 LBD were studied by ITC, NMR and computer docking. Our 
results demonstrate that the high-affinity ephrin-binding pocket of the Eph receptors 
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1.1   Biological background 
 
1.1.1   CNS injury 
 
    CNS (Central Nervous System, including brain and spinal cord) injuries, induced 
by stroke, traumatic injury, or neurodegenerative diseases, could be permanently 
disabling because the transected axons in CNS could not regenerate beyond the lesion 
site. Potential consequences of these CNS injuries include memory loss, inability to 
concentrate, speech problems, motor and sensory deficits, and behavioural problems. 
Each year in the United States, more than 2 million people suffer from traumatic brain 
injuries, over 500,000 people suffer from stroke, and at least 10,000 people suffer 
from spinal cord injuries. So far, the primary treatments are based on physiotherapy 
and it is estimated that only 0.9 % of the patients will have completed neurological 
recovery. Therefore, there is a huge unmet medical need for treating CNS injury. 
 
1.1.2   Mechanisms that inhibit axonal regeneration 
    It was observed long ago that unlike axons in peripheral nervous system, severed 
axons in the CNS do not have the ability to grow significant distance (Ramon, 1928). 
Moreover, the study in 1980 showed that the peripheral nerve implanted in CNS can 
not grow out of long distance (Weinberg EL, 1980). Thus, the failure of axons in CNS 
to regenerate is due to the non-permissive environment they inhabit. If the inhibitory 
factors could be removed or blocked, or if suitable growth-promoting agents added, 
the axons might re-grow through the lesion site. 
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Several growth inhibitors have been identified which are either components of the 
extracellular matrix present in the glial scar or molecules associated with CNS 
myeline. 
 
Figure1.1  Schematic representation of the CNS injury site (Glenn Yiu, et al, 2006). 
 
1.1.3   Inhibitors from glial scar and associated with CNS myeline 
Injury to the adult CNS often results in the transection of nerve fibres and damage 
to surrounding tissues. The distal ends of the severed axons form characteristic 
dystrophic growth cones that are exposed to the damaged glial environment. During 
the early phase of injury, myelin associated inhibitors from intact oligodendrocytes 
and myelin debris can restrict axon regrowth. Recruitment of inflammatory cells and 
reactive astrocytes over time leads to the formation of a glial scar, often accompanied 
by a fluid-filled cyst. This scarring process is associated with the increased release of 
chondroitin sulphate proteoglycans, which can further limit regeneration. Together, 
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these molecular inhibitors of the CNS glial environment present a hostile environment 
for axon (Glenn Yiu et al, 2006). 
 
1.1.3.1   Inhibitors by components of the glial scar 
     Key classes of inhibitory molecules are 1) Chondroitin sulphate proteoglycans; 2) 
ephrins; 3) semaphorins. All of them are up-regulated after injury. Chondroitin 
sulphate proteoglycans are components of the CNS extracellular matrix; the precise 
mechanism by which they cause growth inhibition is not known, but the fact that they 
do so is well established (McKeon RJ et al, 1995; Snow DM et al, 1990). Ephrins and 
their Eph receptors are a family of membrane proteins that are involved in axon 
guidance during development, but are also present in the CNS in adulthood. Binding 
of ephrins on one cell to their receptors on another activates bidirectional signalling 
pathways that in neurons lead to the collapse of the growth cone (Holland SJ et al, 
1996). Semaphorins are a large family of membrane-bound and secreted proteins that 
are also involved in axon guidance during development. Upregulated production of 
Sema-3A by the meningeal cells that migrate in to form the lesion core is again 
inhibitory to axonal growth (De Winter F et al, 2002). 
 
1.1.3.2   Inhibitors associated with CNS myeline 
   Cultured neurons grow readily on substrates of myelin extracted from peripheral 
nerve, but not on beds of mature oligodendrocytes or isolated CNS myelin (Schwab 
ME et al, 1988). The proteins Nogo-A (Chen MS et al, 2000) and myelin-associated 
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glycoprotein have been identified as mediators of the growth-suppressive effects of 
CNS myelin. In addition, oligodendrocytes secrete the inhibitory protein tenascin R. 
    My thesis puts emphasis on Nogo-A, a widely studied inhibitor, and EphA4, a 
newly discovered agent involved in neuron regeneration. Thus, the following review 















Figure1.2  Glial inhibitors and intracellular signalling mechanism 
(Glenn Yiu, et al, 2006). 
61.1.4   NogoA as an Inhibitors of Axon Regeneration in CNS 
Nogo is a member of the reticulon family of membrane proteins, and at least three 
isoforms (Nogo-A, -B and -C) are generated by alternative splicing and promoter 
usage.  
Among these, Nogo-A is best characterized, owing to its high expression in CNS 
oligodendrocytes (Huber, A. B. et al, 2002). Structure–function analyses support the 
presence of two inhibitory domains: a unique amino-terminal region (amino-Nogo) 
that is not shared by Nogo-B and Nogo-C (Oertle, T. et al, 2003), and a 66 amino acid 
loop (Nogo-66) that is common to all three isoforms (Prinjha, R. et al, 2000). Nogo-
66 contains three helices and with the long-range packing between the second and 
third helix, whereas the amino terminal region was demonstrated as intrinsically 










 Figure1.3  Schematic representation of Nogo family (Oertle, T. et al, 2003)
Figure1.4  NMR solution structure of Nogo-66 (Li M et al, 2004) 
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    Nogo-A has been demonstrated to be a potent neurite growth inhibitor and plays a 
key role both in the restriction of axonal regeneration after injury and in structural 
plasticity of the CNS of higher vertebrates. In vivo neutralizing Nogo-A by its 
antibody has been shown to enhance sprouting and functional recovery after cervical 
lesion in rat and adult primates. In addition, Nogo-A was also identified to be 
essential for the tubular network formation of ER (Voeltz G.K. et al, 2006). Most 
recently, a role of Nogo-A in synapse integrity has also been suggested and 
overexpression of Nogo-A led to destabilization and retraction of nerve terminal 
(Jokic N. et al, 2006). 
   Intracellular Nogo-A protein level is believed to correlate with stroke (Li S. et al, 
2006), as well as other neurodegenerative diseases such as ALS (Jokic N. et al, 2005) 
and Alzheimer’s disease (Gil V. et al, 2006). These observations indicate that the 
intracellular Nogo-A protein level is essential to the functions of Nogo-A in cell. As a 
result, it is of significant meaning to know how the Nogo-A protein level is regulated 
in vivo. 
   Recently, our collaborators found that WWP1, an E3 ubiquitin ligase, can interact 
with Nogo-A, and initiate the ubiquitination of Nogo-A, subsequently down-regulate 
the intracellular Nogo-A protein level. As this phenomenon was also observed at the 
axonal sprouting region of the mice stroke model, WWP1 mediated ubiquitination is 
likely to play an important role in Nogo-A axon regeneration inhibition. The 
investigation of how WWP1 interact with Nogo-A would have significant meaning in 
Nogo-A involved neuron diseases by providing the interaction mechanism 
information. In my thesis, the binding between WWP1 and Nogo-A was studied by 











   
Figure 2.5  Schematic representation of Nogo-A degradation (Qin H. et al, 2008) 
 
1.1.3 Eph and ephrin and their function in axon regeneration in CNS 
Eph proteins constitute a large family of receptor tyrosine kinases that bind to 
ligands called ephrins. The Eph and ephrin protein families are each divided into A 
and B subclasses based on sequence homology, membrane anchorage, and binding 
preference for each family member. There are 10 EphA and 6 EphB receptors known 
at present, while 6 ephrin-A and 3 ephrin-B proteins have been identified. Ephrin-A 
proteins are attached to the cell membrane by a glycophospatidylinositol (GPI) anchor, 
while ephrin-B proteins have a transmembrane region and a short, highly conserved 
cytoplasmic tail with a PDZ (postsynaptic density-95/Discs large/zona occludens-1)-
binding domain (Martinez A. et al, 2005; Song J. et al, 2002; Torres R. et al, 2008). 
Eph receptors consist of a highly conserved N-terminal extracellular ligand binding 
domain, followed by a cysteine-rich domain, two fibronectin III repeats, a 
juxtamembrane region, and an intracellular kinase domain with a PDZ binding motif 
(Flanagan JG et al, 2008). 
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In the nervous system, Ephs and ephrins have been most extensively studied for 
their developmental roles in axon guidance, topographic mapping, hindbrain 
segmentation, and neural crest cell migration (Wilkinson DG et al, 2005; Henkemeyer 
M. et al, 2003). Ephs and ephrins are not only developmental molecules but also play 
important role in adult nervous system. Evidence showed that, Ephs and ephrins can 
modulate synaptic function by regulating dendritic spine formation (Henkemeyer M. 
et al, 2003; Ethell IM et al, 2001; Murai KK et al, 2003), NMDA receptor clustering, 
and potentiation of calcium influx (Takasu MA et al, 2002; Dalva MB et al, 2000). 
Moreover, Ephs and ephrins also are involved in the proliferation and progenitor cells 
in neurogenic regions (Depaepe V et al, 2005; Katakowski M et al, 2005; Ricard J et 


























    
  Outsides the nervous system, ephrinB2 on arterial and EphB4 on venous endothelial 
cells mediate embryonic vascular assembly and atteriovenous differentiation (Gerety 
SS et al, 1999; Adams RH et al, 1999). EphrinB2 and EphA2 also are linked to 
neovascularization and tumor angiogenesis (Gale NW et al, 2001; Shin D et al, 2001; 
Brantley DM et al, 2002; Noren NK et al, 2004; Brantley-Sieders DM et al, 2005). 
Many Eph and ephrin family members are found in tumors including those of the 
Figure 1.6  Eph receptor structure and signalling (Yona Goldshmit et al, 2006) 
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breast, lung, colon, prostate, and in glioblastoma as well as melanoma (Surawska H et 
al, 2004), where their expression level is correlated with malignancy to some degree.  
It is thought that Eph/ephrin promotes tumor metastasis by negatively regulating cell 
adhesion and enhancing neovascularisation (Wimmer-Kleikamp SH et al, 2005; 
Dodelet VC et al, 2000). 
 
1.1.6   Eph/ephrin functions in axon regeneration 
In the last several years, much evidence has documented that the Ephs and 
ephrins play important roles after CNS damage in the brain (Biervert C et al, 2001; 
Moreno-Flores MT et al, 1999), optic nerves (Liu X. et al, 2006), and spinal cord 
(Bundesen LQ et al, 2003; Fabes J et al, 2006; Miranda JD et al, 1999; Willson CA et 
al, 2002; Willson CA et al, 2003), like EphB2, EphB3, EphA4 and ephrinB2. EphB3 
plays a role in retinal ganglion cell axonal plasticity and initial axon attempts at re-
growth after injury, ephrinA2 and ephrinA3 can promote neuronal survival and 
neurite outgrowth after optic nerves injury. In contrast with the promotion effect, 
some Eph/ephrins directly inhibit the re-growth of injured neuron or indirectly inhibit 
the re-growth by form the glial scar. 
Evidence show that after spinal cord injury, damaged corticospinal tract axons 
express EphA4, and are surrounded by astrocytes expressing ephrinB2 (Jez Fabes et 
al, 2006). EphA4 is also up-regulated in astrocytes in injured wide-type spinal cord, 
while regenerating axons express ephrinB3 (Jez Fabes et al, 2006). Whereas EphA4 
homozygous null mice study showed that EphA4-/- axons were able to cross the 
lesion site in greater number than in wide-type mice (Yona Goldshmit et al, 
2004).These evidence indicate that EphA4 may sense the repellent growth signals 
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from environment by interacting with ephrinB2 and ephrinB3. Interestingly, in the 
later work, Douglas Benson et al found that ephrinB3 showed equally inhibitory 
activity as other three myelin associated inhibitors for EphA4-positive neurons, which 
further confirms that the EphA4/ephrinB3 pathway has inhibitory effect on the injured 









1.1.7   Structure of Eph receptor and its complex with ephrins ligands 
    Due to the wide distribution in vitro and huge signalling network comprised, the 
structure studies to Eph receptor family and its binding partners have attracted 
intensive attention from investigators. These studies have substantially improved our 
understanding on Eph receptor structure as well as their binding mechanism with 
ephrin ligands (Himenan et al, 1998; Himenan et al, 2001; Himenan et al, 2004; 
Chrencik JE et al, 2006). From these released structures, Eph receptor ectodomain 
adopts a Greek key topology constituted by an 11 β-stranded barrel. The concave 
sheet is comprised of strands C, F, L, H, and I, and the convex sheet of strands D, E, 
Figure 1.7   Eph and ephrin function after spinal cord and optic nerve injury in 
mice (Yona Goldshmit et al,)
13 
 
A, M, G, K, and J, which are connected by loops of variable length. The formation of 
the complex between Eph receptors and ephrins is centered around the insertion of the 
solvent exposed ephrin G-H loop into the hydrophobic channel formed by the convex 
sheet of four β-strands, together with the D-E, J-K and G-H loops of the Eph receptor. 
These interactions are mostly hydrophobic and, together with an adjacent mostly polar 
surface region, form the high affinity interface of Eph receptor-ephrin complexes, 
which is involved in receptor-ephrin dimerization (Himanen JP et al, 2001; Himanen 
JP et al, 2004; Chrencik JE et al, 2006; Himanen JP et al, 2009). Other interfaces 
contribute to Eph-ephrin binding, including: (1) additional residues on both the 
receptor and ephrin surfaces, (2) a low affinity interface also located in the binding 
domains of Eph receptors and ephrins, which was identified in the EphB2-ephrin-B2 
complex and appears to mediate the association of two receptor-ephrin dimers 
(tetramerization) (Himanen JP et al, 2004), and (3) an interface involving the 
cysteinerich region adjacent to the Eph receptor ligand binding domain, which was 
identified by mutagenesis in EphA3-ephrinA5 complexes but has not been structurally 
characterized and which might be implicated in higher order clustering.  
    While Eph receptors interact promiscuously with ephrins of the same class, they 
rarely interact with ephrins of the other class. A variety of factors appear to contribute 
to class specificity. B class Eph/ephrin interactions are characterized by a compact 
conformation, which necessitates considerable structural rearrangements of both the 
receptor and the ephrin, while EphA receptors and ephrin-A ligands appear to 
undergo smaller rearrangements when forming a complex (Himanen JP et al, 2009). 
Differences in critical residues located in the interacting regions and sequence 
differences in the class specificity H-I loop of the Eph receptors seem to also play a 
role in class specificity (Himanen JP et al, 2001; Himanen JP et al, 2004; Chrencik JE 
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et al, 2006; Himanen JP et al, 2009). However, examples of interclass binding also 
exist: EphB2 can bind ephrin-A5 and EphA4 can bind all three ephrin-B ligands 
(Pasquale EB, 2004). 
EphA4 binding to ephrin-B ligands is also weaker than to ephrin-A ligands. 
However, EphA4-ephrin-B interclass interactions have been shown to be 
physiologically relevant in many biological systems. For example, EphA4 interaction 
with ephrin-B1 stabilizes blood clot formation through an integrin-dependent 
mechanism (Prévost N et al, 2005) while EphA4 interaction with ephrin-B2 and/or 
ephrin-B3 regulates cell sorting in the rhombomeres and branchial arches of the 
developing hindbrain (Smith A et al, 1997; Xu Q et al, 1999), somite morphogenesis 
(Barrios A et al, 2003), axon guidance and circuit formation in the developing spinal 
cord (Kullander K et al, 2001; Kullander K et al, 2001; Yokoyama N et al, 2001; 
Kullander K et al, 2003), and inhibition of axon outgrowth by myelin (Benson MD et 
al, 2005). The distinctive ability of EphA4 to bind both ephrin-A and ephrin-B 
ligands makes it an attractive model to understand the structural principles underlying 
the selectivity versus promiscuity of Eph receptor-ephrin interactions, but no 
structural information has been available for free EphA4 and EphA4-ephrin 
complexes. In this thesis, high resolution 3D structures of EphA4 and its complexes 
with ephrin ligands will be determined. This study will reveal structure 
characterization of EphA4 ligand binding domain and its binding mechanism between 
EphA4 and its ephrin ligands and find out how the receptors recognize different 





1.1.8   Organic compounds as small antagonist of EphA4 
As an important target for drug design, a variety of molecules that inhibit 
interaction between Eph receptors and ephrins ligands are investigated. A number of 
peptides indentified by phage display show their selectivity, high binding affinity with 
some of Eph receptors (Murai KK et al, 2003). Other molecules that modulate Eph-
ephrin interactions have also been identified, including antibodies and soluble forms 
of Eph receptors and ephrins extracellular domains (Ireton, R. C. et al, 2005; Noren, 
N. K. et al, 2007; Wimmer-Kleikamp, S. H. et al, 2005). Several small molecule 
inhibitors of Eph receptor kinase domain have also been reported (Caligiuri, M. et al, 
2006; Karaman, M. W. et al, 2008; Miyazaki, Y. et al, 2008; Kolb, P. et al, 2008). 
These inhibitors occupy the ATP binding pocket of the receptors and are usually 
broad specificity inhibitors that target different families of tyrosine kinases (Caligiuri, 
M. et al, 2006; Karaman, M. W. et al, 2008). Epigallocatechin gallate, a green tea 
derivative known to inhibit several tyrosine kinases, has also been shown to inhibit 
EphA receptor-mediated a human umbilical vein endothelial cell migration and 
capillary-like tube formation, but the mechanism of action of this molecule has not 
been elucidated. Therefore, the high-affinity ephrin binding pocket of the Eph 
receptors appears to be an attractive target for design of small molecules capable of 
inhibiting the Eph receptor signaling by blocking ephrin binding. By high throughput 
screening approach, Noberini R. et al identified two isomeric 2,5-dimethylpyrrolyl 
benzoic acid derivatives that selectively inhibit ephrin binding to EphA4 and EphA2 
as well as the functions of these receptors in live cells (Noberini R et al, 2008). This is 
a very important start point for drug design of EphA4 receptor involved pathways. It 
is of significant interest to gain structural insight into the binding interactions between 
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EphA4 and two molecules, hoping this study will develop small organic antagonist 
with high binding affinity and specificity. 
 
1.1.9   Dynamics study of proteins 
Although by X-ray and NMR, investigators have produced many pictures of protein 
structures, these static 3D structures alone can not completely explain results from 
functional biological assays, nor do they necessarily illuminate the path for protein 
engineering or rational drug design. This is because a three dimensional static 
structure provides a description of the ground state of the molecule. Macromolecular 
function is, however, in many cases, highly dependent on excursions to excited 
molecular states and hence intimately coupled to flexibility. Recently evidence has 
accumulated to suggest that protein dynamics may play a critical role in the biological 
functions including signal transmission (Baldwin AJ et al, 2009; Henzler-Wildman, K 
et al, 2007; Smock, R.G. et al, 2009). Therefore, a complete and much more useful 
description of the structure of a molecule will require an understanding of how the 
structure changes with time and bridge the gap between static and dynamic pictures of 
molecular structure and to demonstrate how motion relates to function. In this thesis, 
dynamics of free EphA4 ligand binding domain and its complexes with small 
antagonists will be studied, and more mechanism behind interaction between EphA4 






1.2 Protein NMR 
 
1.2.1 Physical basis of NMR spectroscopy  
    Atoms and molecules have a variety of quantised energy levels. Many 
spectroscopic techniques take advantage of transitions between these energy levels 
with different ΔE values being related to particular frequency-ranges of the 
electronmagnetic spectrum by equation  
                                               ܧ ൌ ݄ݒ                                             (E1.1) 
Where h is Planck’s constant and v is frequency.  
Nuclear magnetic resonance spectroscopy is a spectroscopic technique which takes 
advantage of magnetic spin. Magnetic spin is a property of many different types of 
atoms. Take 1H as example, this nuclei can be regarded as a spinning positively 
charge. This generates a magnetic field which will have a magnetic spin moment, µ. If 
an external magnetic field (B0) is applied to such a nucleus, it can orientate itself 
either with (parallel) or against (antiparallel) this field like a bar-magnet does in the 
earth’s magnetic field on the macroscopic scale. These two orientations are referred to 
as spin states and are distinguishable by their different spin quantum numbers, mI, 
which are respectively, -1/2, and +1/2. The magnetic spin moment ‘wobbles’ or 
processes around the axis of the external magnetic field by an angle, θ, and rotates 
around this axis with a particular frequency, ω, which is called the Larmore frequency. 
The potential energies of the two spins states are given by  
(Low energy spin state: mI=-1/2) 
                                 ܧ ൌ െߤܤ0sin ߠ                               (E1.2) 
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(High energy spin state: mI=1/2) 
                                              ܧ ൌ ߤܤ0sin ߠ                                    (E1.3) 
The energy difference, ΔE, between them is therefore given by          
                                              ߂ܧ ൌ 2ߤܤ0 sin ߠ                                   (E1.4) 
ΔE is proportional to the applied magnetic field. Early work on biomolecules used 
magnetic field strengths of only approximately 40MHz. Modern NMR spectrometers 
use much larger field strengths (500-800MHz) which give rise to larger ΔE values and 
yield NMR spectra of much higher resolution. 
NMR spectroscopy depends on absorption of electromagnetic radiation from the 
radiowave part of the spectrum causing the nucleus to undergo a transition from a low 
to a high energy spin state. The precise value of v required for the transition depends 
on both the identity of the nucleus and on its precise chemical environment. Because 
of this, NMR spectra can yield precise information on the structure/composition of 
biomolecules and on processes in which they are involved. 
A wide range of different elements have nuclei which are amenable to study by 
NMR spectroscopy. Those which are most relevant to the study of biological 
macromolecules are listed in Table 1.1, the nucleus which is most sensitive to the 
detection by NMR is hydrogen, and this is by far the most important nucleus for the 
study of biological macromolecules. Other nuclei such as 15N, 13C are nowadays 





Table1.1   Properties of nuclei of interest on NMR studies of proteins 





1H 1/2 500.0 99.98 1.00 
2H 1 76.7 1.5×10-2 9.65×10-3 
3H 1/2 533.3 0 1.21 
12C 0 -- 98.89 -- 
13C 1/2 125.7 1.108 1.59×10-2 
14N 1 36.1 99.63 1.01×10-3 
15N 1/2 50.7 0.37 1.04×10-3 
16O 0 -- 100 -- 
17O 5/2 67.8 3.7×10-2 2.91×10-2 
19F 1/2 470.4 100 0.83 
31P 1/2 202.4 100 6.63×10-2 
 
    The first published NMR spectrum of a biological macromolecule was the 40MHz 
1H spectrum of pancreatic ribonuclease reported in 1957. The most that could be 
deduced from this spectrum was that it was consistent with the amino acid. The 
subsequent years, perhaps particularly the last twenty years, have seen astonishing 
developments in instrumentation and methodology which have enormously increased 
the power of NMR, notably in its application to study the conformations and 
interactions of biological macromolecules. The most important of these developments 
include the following: 
1. The construction of higher field spectrometers, with a consequent increase in 
sensitivity and spectral dispersion. 
2. The development if pulse Fourier transform methods, in which the radiofrequency 
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radiation is applied to the sample in the form of a more or less complex sequence 
of pulses, and the spectrum obtained by Fourier transformation of the response if 
the nuclear spins to these pulse trains. 
3. The development of multi-dimensional NMR, in which resonance intensity is 
recorded as a function of two, three, or four frequency variables. 
 
1.2.2   Chemical shift 
Because instrumental limitations, it is difficult to measure v values accurately. To 
standardize measurements between different NMR spectrometers and different 
experimental conditions, it is usually include a reference (normally TMS or deuterium 
signal) with the sample to be analyzed.  The frequency corresponding to the resonance 
condition for each transition in the sample is then expressed as the chemical shift, δ, 
in parts per million (ppm) as follows: 
                                    ߜ ൌ ሺߥ௦ െ ߥ௥௘௙ሻ/ݒ௥௘௙ ൈ 10଺                          (E1.5) 
What makes NMR especially informative is the fact that precise radiation 
frequency, v, corresponding to the resonance condition for each type of nucleus at a 
given applied magnetic field strength can be affected by its immediate chemical 
environment. This is due to the magnetic effect of nearby nuclei on that of nuclei 
undergoing transition. Generally speaking, the factors affect chemical shift are 
electron density, electronegativity of neighbouring groups and anisotropic induced 
magnetic field effects. In protein NMR spectrum, each atom with spin will have 
specific chemical shift, which makes protein studied by NMR possible. Moreover, 
chemical shift provides useful information in identifying protein secondary structure. 
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Characteristic chemical shift deviations of Hα, C=O, Cα, and Cβ from random coil 
values are good indicators for the existence of α-helix or β-sheet (Figure 1.8) (Wishart 

















Figure 1.8   Correlation between chemical shift deviation and 2nd 
structure (Wishart DS et al, 1994) 
Figure 1.9   Correlation between J-coupling and 2nd structure (A. Pardi et al, 1984) 
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1.2.3   J coupling 
Nuclei experiencing the same chemical environment or chemical shift are called 
equivalent. Those nuclei experiencing different environment or having different 
chemical shifts are nonequivalent. Nuclei which are close to one another exert an 
influence on each other's effective magnetic field. This effect shows up in the NMR 
spectrum when the nuclei are nonequivalent. If the distance between non-equivalent 
nuclei is less than or equal to three bond lengths, this effect is observable. This effect 
is called spin-spin coupling or J-coupling. J-coupling contains information about 
dihedral angles, which can be estimated using the Karplus equation: 
                                 ܬሺ׎ሻ ൌ ܣ cosଶ ׎ ൅ ܤ cos׎ ൅ ܥ                               (E1.6) 
Where J is the 3J coupling constant, ϕ is the dihedral angle, and A, B, and C are 
empirically-derived parameters whose values depend on the atoms and substituents 
involved. 
Similar to chemical shift deviation of residues in structured region from those in 
random coil, deviation of 3JNHHα values from random coil values provides valuable 
secondary structural information. In folded proteins, β-Structures are characterized by 
large coupling constant values in the range 8~10 Hz, while α-helical structures are 
characterized by values in the range 3~5 Hz. In unfolded proteins, however, the 
coupling constants are about 6~7.5Hz due to the fact that conformational fluctuation 





1.2.4   NOE (Nuclear Overhauster Effect) 
    Overhauster effect was first discovered by Albert Overhauster in 1953. It is the 
phenomenon that the transfer of spin polarization from one spin population to another 
via cross-relaxation in nuclear magnetic resonance spectroscopy. The original 
Overhauser effect was described in terms of polarization transfer between electron 
and nuclear spins, but is now mostly used for transfer between nuclear spins, 
the Nuclear Overhauser Effect (NOE or nOe). A very common application 
is NOESY (Nuclear Overhauser Effect Spectroscopy), an NMR technique for 
structure determination of macromolecular motifs. 
NOE differs from spin coupling in the respect that NOE is observed through space, 
not through bonds. Thus, all atoms that are in proximity to each other give a NOE, 
whereas spin coupling is observed only when the atoms are bonded to same or 
neighboring atoms. Furthermore, the distance can be derived from the observed NOEs, 









Figure 1.10   NOE patterns associated with protein 2nd structure (Wuthrich K, 1986) 
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1.2.5   NMR relaxation and protein dynamics 
   In NMR spectroscopy, the term relaxation describes several processes by which 
nuclear magnetization prepared in a non-equilibrium state return to the equilibrium 
distribution. When an excited magnetic moment relaxes back to equilibrium, the z 
axis, there are two components of this relaxation for isotropic systems in the absence 
of chemical exchange: longitudinal or spin lattice (T1) and transverse or spin-spin 
(T2). T1 is always at least slightly slower than T2. 
    Biomolecules are intrinsically flexible and dynamic systems. These characteristics 
critically assist them in their quest to perform biological functions. Nuclear magnetic 
resonance (NMR) spectroscopy can be used to monitor the dynamic behaviour of a 
protein at a multitude of specific sites. Moreover, protein movements on a broad 
range of timescales can be monitored using various types of NMR experiments — 
nuclear spin relaxation rate measurements report the internal motions on fast (sub-
nanoseconds) and slow (microseconds to milliseconds) timescales as well as the 
overall rotational diffusion of the molecule (5–50 nanoseconds), whereas rates of 
magnetization transfer among protons with different chemical shifts and proton 
exchange report movements of protein domains on the very slow timescales 
(milliseconds to days). These features make NMR a unique and powerful tool in 
studying protein dynamics related to protein functions, and there has been a 
tremendous growth in these applications since the review by Lewis Kay in Nature 
Structural Biology in 1998. There is an impressive body of evidence indicating that 
the target binding sites of many proteins are flexible. NMR relaxation measurements 
are very useful in identifying which residues in a binding site are flexible. 
Significantly, these measurements are useful even when a high resolution X-ray 
structure is available, because crystal contacts may quench local motions. In some 
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instances flexibility at these sites may stabilize the unbound state, while in others it 
may be necessary for functions.  
     In NMR relaxation experiments, nuclear spin magnetization is excited by the 
application of electromagnetic radiofrequency fields and the return of the spin 
magnetization to thermal equilibrium is monitored using multidimensional NMR 
experiments. Commonly measured relaxation parameters are longitudinal relaxation 
times (T1), transverse relaxation times (T2), heteronuclear Overhauser effects (NOEs).  
   
1.2.6   Structure determination by NMR 
    The chemical shift associated with a nucleus possessing magnetic spin may be 
altered by its magnetic environment. Bond and nearby nuclei will interact with each 
other and multiple-dimension NMR can be used to detect these interactions. Therefore, 
NMR could be a major method for structure determination of biomolecules in solution. 
The overall strategy for determining structure from 2-D NMR for proteins up to 
approximately 100 residues was developed by Kurt Wuthrich in the early 1980s. 
More sophisticated NMR experiments suitable for larger proteins based on this 
overall approach were developed later. In general, the strategy using NMR to solve 
















1.2.6.1   Assignment (backbone and side chain) and restraints (distance, dihedral 
angle) 
The most simple and straightforward method of backbone resonance assignment 
involves the use of 15N, 13C labelled protein and the measurement of CBCACONH 
and HNCACB spectra. Large proteins give worse NMR spectra, because they tumble 
more slowly. For this reason the above two experiments of larger proteins (> 150 
residues) are often not of sufficient quality to be able to carry out a full assignment. In 
this case a good option is the use 
of HNCA, HN(CO)CA, HNCO and HN(CA)CO spectra. 
Standard triple resonance backbone assignment of proteins is based on 
the CBCANNH and CBCA(CO)NNHspectra. The idea is that the CBCANNH 
correlates each NH group with the Cα and Cβ chemical shifts of its own residue 
                                                Step1: Sequential resonance assignment 
(HNCACB, CBCACOHN, CCCCONH, 2D-TOCSY, 2D-NOESY, HSQC-TOCSY, HSQC-NOESY, etc.) 
 Step2: Identification of torsion angle restraints 
                    (TALOS prediction, COSY) 
 Step3: Identification of distance restraints by through-space NOEs 
                                                     (NOESY) 
 Step4: Structure calculation and refinement 
Figure1.11   Flow chart of structure determination 
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(strongly) and of the residue preceding (weakly). The CBCA(CO)NNH only 
correlates the NH group to the preceding Cα and Cβ chemical shifts. The Figure 
below shows how this can be used to link one NH group to the next into a long chain. 
 
Figure 1.12   Sequential assignment by CBCACONH, HNCACB 
    In practise, using the CBCANH and CBCA(CO)NH spectra this looks like this 
(Cαs are shown in dark blue, Cβs in light blue): 
 
Figure 1.13   Sequential assignment by CBCACONH, HNCACB 
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After the sequential assignment, the chemical shift of backbone amine, hydrogen, 
and Cα, Cβ can be collected. Next, we need to do the assignment of side chain. A 
straight forward method is to begin with a set 
of HBHA(CO)ONH, HCC(CO)NNH and CC(CO)NNH spectra. These will provide 
the hydrogen and carbon side-chain chemical shifts for the residue preceding each NH 
group. For longer side chains not all peaks may neccessarily be visible, so that this 
may not be sufficient. Therefore, another spectra HCCH-TOCSY is quite useful to 
identify more chemical shifts because the excellent sensitivity. The HCCH-TOCSY 
will at any one carbon position show in one dimension the chemical shift of the 
hydrogen which is attached to the carbon and in another the other hydrogens 
belonging to that side chain.  
 
Figure 1.14   Side chain assignment by HCCH-TOCSY 
 
For smaller proteins, it is possible to do the backbone assignment using just 15N-
labelled protein. The spectra used for this are the 15N-NOESY-HSQC and the 15N-
TOCSY-HSQC. The 15N-NOESY-HSQC will show for each NH group all 1H 
resonances which are within about 5-7Å of the NH hydrogen. Assignment is done on 
the assumption that the two neighbouring NH groups are always visible. Thus two NH 
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groups can be linked because they each have an NOE to the other NH group. 
Meanwhile, the side chain chemical shifts can also be read from these spectra. 
 
Figure 1.15   NOE assignment by 15N-NOESY 
 
After the assignment of all the isotope atoms and protons, the more important and 
troublesome part is the assignment of NOE generated by neighbour atoms. Current 
assignment could be used to generate chemical shift index. The chemical shift index 
will give clue of the secondary structure of the protein, as shown in figure 1.8, which 
will be very helpful in the assignment of NOE. NOE pattern was shown in figure 1.10. 
After finishing all the assignments, the distance range between protons could be 
determined from the van der Waal’s radii—lower bonds, and the NOE intensity—
upper bonds. According to NOE intensity, these NOEs can be categorized into 
“weak”, “middle”, “strong” and the corresponding distance are 1.8Å, 2.5 Å, and 5.0 Å. 
Dihedral angle restraints are usually calculated by TALOS, which is a free 
software calculates protein backbone torsion angle by inference from measured Cα 
and Cβ chemical shifts.  
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1.2.6.2   Structure calculation and evaluation 
There are many procedures for protein tertiary structure determination from NMR 
data. All these approaches aim to sample conformational space whilst at the same 
time satisfying a set of constraints. One available approach is model building, which 
uses the existing structure to determine the structure in question. A very different 
approach is probabilistic in nature and represents each atom by mean atomic position 
and variance about this position.  
An alternative method is adopted by distance geometry, which is used in my 
research work and be illustrated in detail here. This method builds structure from 
internal distances. If a starting structure exists, restrained molecular dynamics can be 
used to refine it. A random folded starting structure is generated by empirical data, 
such as bond lengths and bond angles, together with amino acid sequence. Each 
known parameter will be given potential energy, and it will give a minimal energy if 
the calculated distance or angle coincides with input values. After each simulation 
step, the energy potential is recalculated for the new atomic positions and a further 
step follows. The step is iterated; search the energy hyperspace for a global minimum. 
After simulation steps at high temperature, the temperature (atomic velocities) is 
slowly reduced in many steps. The force constants in experimental constraints are 
raised simultaneously in each step. 20 or more different starting structures with 
random folds are used to generate a family of structures.  
Once an ensemble of structures has been generated, it is necessary to assess them. 
The first question need to be addressed is how well the resulting structures satisfy the 
initial set of constraints. Usually a violation greater than 1Å is an indication of a 
serious problem and causes very high target function. The constraints causing huge 
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violation should be re-checked in NMR spectra or removed, until the target function 
decreased to an acceptable value. Verification of whether the backbone torsion angles 
of the structure lie in the allowed region of is also necessary. The RMS deviation of 
the ensemble from the esemble average is also commonly used to determine the 
“goodness” of the structures. 





























1.3 Objectives and Contributions 
Nogo-A is the most intensively studied neuron regeneration inhibitor, and EphA4 is 
newly discovered an active role in the pathway inhibiting neuron regeneration. No 
doubly, their structure and binding partner study will help us to understand the 
molecular mechanism of the interaction with their binding ligand, and provide 
information in the design of drug to block the inhibition pathway, promoting CNS 
neuron regeneration. Our research will aim at the structure study of Nogo-A/WWP1, 
EphA4 structures both in free and complex states, as well as dynamics study for 
EphA4 and its complexes. Our objectives will focus on the following aspects: 
1.3.1  Structural illumination to Nogo-A and its newly discovered binding 
partner WWP1 
     Nogo-A is intensively studies due to its inhibitory ability to injured neuron 
regeneration. Moreover, its protein level is closely related with diseases such as stroke, 
as well as other neurodegenerative diseases such as ALS and Alzheimer’s disease. 
Recently, our collaborators found that WWP1 interacted with Nogo-A and regulated 
its protein level, and their binding mechanism will be elucidated in this thesis by 
structural study. This work definitely is highly important and could provide clue or 
direction in drug design to Nogo-A protein level regulation.  
1.3.2  Structure determination of EphA4 LBD and EphA4/ephrinB2 complex by 
X-ray 
    The huge signalling network composed by Eph receptors and ephrin ligands has 
attracted intensive investigation in recent years. EphA4 is a receptor capable of 
interacting with ephrins of both classes to generate a diverse spectrum of biological 
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activities. However, there is no structural study on free EphA4 molecule and its 
complexes with ephrin ligands. This thesis will focus on the structure determination 
of EphA4 and its complex with ephrinB2 ligands by X-ray. This work will be very 
important in understanding the structure and binding mechanism of Eph receptor and 
ephrin ligands. 
1.3.3  Structural study of the complexes between EphA4 LBD and its small 
organic antagonists 
Although some peptides, proteins, and small organic compounds have been 
identified to interrupt interactions between Eph receptors and ephrin ligands, they are 
all not suitable for further drug development due to biodegradability, poor specificity 
etc.. Therefore, the design of small antagonists targeting high affinity binding channel 
of Eph receptors has attracted intensive attention. Two isomeric 2,5-dimethylpyrrolyl 
benzoic acid derivatives were identified that can selectively inhibit ephrin binding to 
EphA4 and EphA2 as well as the functions of these receptors in live cells. This is the 
first time that people identified organic compounds selectively bind to high affinity 
binding channel of Eph receptor. In order to improve their specificity and binding 
affinity, structural insight into the binding interactions between EphA4 and two 
molecules will be studied. Their binding details will be elucidated by various 
biophysical methods. Our work will be a very important starting point for drug 
development targeting high affinity binding channel of Eph receptors.  
1.3.4   NMR structure of EphA4 LBD and its dynamics study 
With the accumulation of protein structures, people realized that protein is flexible 
in solution. Moreover, recently, evidence is accumulated to suggest that protein 
dynamics may play a critical role in the biological functions including signal 
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transmission. However, most investigators have not included protein dynamics study 
in their work. Unlike X-ray structure, most of which are rigid, NMR solution structure 
shows more information of protein dynamics. Therefore, NMR structure and the 
dynamics of EphA4 LBD will be studied in this thesis. The dynamics study of 
proteins will definitely gives more information about the protein. In addition, it may 
help to understand how protein dynamics affect EphA4 signalling regulation.  
In order to achieve the objectives described above, protein crystallography and 
macromolecular NMR will be applied in this study. Some biophysics methods, 
including ITC, CD, and Biocore, will also be needed. Other techniques, including 
recombinant protein construction, expression and purification are also required. In the 




























2.1   Vector construction 
The construct of Flag-WWP1 was kindly provided by Pu et al (IMCB, 
Singapore). The DNA fragments corresponding to the respective WW domains were 
amplified from WWP1 construct. The DNA fragment of Nogo-A peptide was 
amplified from our vector containing Nogo-A. All the Eph/ephrin DNA fragment 
were amplified by PCR from human embryonic kidney cell cDNA library (293T). All 
the fragments and vectors were double digested by BamH1 and Xho1 (New England 
Biolabs) under 37oC for 3 hours. The digested fragments were purified with QIAquick 
Gel Extraction Kit (Qiagen). Ligation was carried out by mixing digested vector and 
fragment with ratio 1:5, keeping at 16oC overnight. Eph/ephrins and fWW fragments 
were ligated with pET32a, and all the other peptide were ligated with pGEX4T1. 
Ligation product was transformed into E. coli. DH5α. The colony was amplified at 37 
oC overnight, and subsequently extracted plasmid with QIAprep Spin Miniprep Kit 
250 (Qiagen). After confirmed by double digestion or PCR, the DNA sequence of 
positive plasmid was further confirmed by automatic DNA sequencing (ABI). EphA4 
mutants were prepared according to protocol of Stratagene Quick-change site 
mutagenesis kit, and confirmed by DNA sequencing. 
 
2.2   Protein expression and purification 
      Plasmids of WW domains, Nogo-A peptide were transformed into E. coli. BL21 
cells. Constructs of Eph receptor and ephrins ligands were transformed into Rosetta 
Gammi strain to prevent proteins were expressed as inclusion bodies. The cells were 
cultivated under 37℃ until the OD600 value reached 0.6, and IPTG was subsequently 
added into the broth to reach a final concentration of 0.3 mM to induce protein 
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expression for 12 hours at 20ºC. Cells were harvested by centrifugation at 5000rpm 
and lysed by sonication in PBS buffer. The recombinant GST fusion proteins were 
purified by affinity chromatography with Glutathione Sepharose 4B beads (Pharmacia 
Biotech) under native condition. The proteins fused with his-tag were purified with 
Ni-NTA matrices (QIAGEN) under native (Eph and ephrins) or denature (fWW 
domain) condition. The peptides and proteins were released from beads by thrombin 
cleavage overnight under room temperature. WW domains and Nogo-A peptide were 
further purified by HPLC and Eph receptors and ephrins ligands were further purified 
by FPLC. 
 To isotope label proteins required for heteronuclear NMR experiments, 
recombinant proteins were prepared with a similar protocol except for growing the 
cells in M9 medium with addition of (15NH4)2SO4 for 15N-labeling; and 
(15NH4)2SO4/13C-glucose for 15N-/13C- double labeling. 
 
2.3 NMR sample preparation, NMR structure determination, relaxation 
experiments and data analysis 
Sample preparation 
    NMR samples proteins were prepared by dissolving proteins and peptides in 5 mM 
phosphate buffer at pH 6.2 with 0.02% (W/V) sodium azine. Eph and ephrin samples 
were kept in 10mM phosphate buffer at pH 6.3 with 0.02% (W/V) sodium azide. 
NMR experiments to structure determination 
All NMR experiments were acquired on an 800 MHz Bruker Avance spectrometer 
equipped with pulse field gradient units at 25 ºC. The NMR spectra acquired for both 
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backbone and side-chain assignments included 1H-15N HSQC, 15N-edited HSQC-
TOCSY, HSQC-NOESY, as well as tripleresonance experiments HNCACB, 
CBCA(CO)NH, HCCH-TOCSY, and (CCC)CONH. NOE restraints for structure 
calculation were derived from 15N- and 13C-NOESY spectra. The NOE constraints 
involved in the aromatic side chains were collected from two-dimensional 1H NOESY 
spectra in D2O. For more restraints, two dimensional 1H TOCSY, NOESY in D2O as 
well as DQF-COSY in H2O could be acquired to extract NOE distance and dihedral 
angle constraints. NMR data was processed by NMRpipe (Delaglio, F. et al, 1995) and 
analyzed by NMRview (Johnson, B. A. et al, 1994). 
Determination of the NMR structure 
    In the WW4 structure determination, a set of unambiguous NOE restraints 
extracted from three-dimensional 15N HSQC-NOESY and two-dimensional 1H 
NOESY spectra were input to calculate initial structures by CYANA program 
together with dihedral angle restraints derived from 3JαN-NH coupling constants from a 
two-dimensional DQF-COSY spectrum. With the availability of the initial structure, 
more NOE cross-peaks in the two NOESY spectra were assigned with assistance of 
CYANA followed by a manual confirmation. The 10 structures with lowest target 
function values accepted by CYANA were checked by PROCHECK and 
subsequently analyzed by using MolMol and Pymol (http://www.pymol.org). 
    In the EphA4 structure determination, NOE restraints were extracted from three-
dimensional 15N HSQC-NOESY, 13C edited NOESY. Dihedral angel restraints were 
predicted by TALOS. Hydrogen bonds information was extracted by adding D2O in 
freeze dried EphA4 and a set of HSQC spectra were collected after 7min, 2hours, 
4hours, and 24hours. The initial structure was calculated by CYANA program, and 
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more NOEs were confirmed and extracted by taking the initial structure as reference. 
The 10 structures with lowest target function values accepted by CYANA were 
checked by PROCHECK and subsequently analyzed by using MolMol and Pymol. 
Relaxation data collection and analysis 
    15N T1, T1ρ relaxation times, {1H}-15N steady state NOE intensities were collected 
on an 800 MHz Bruker Avance spectrometer equipped with both an actively shielded 
cryoprobe and pulse field gradient units (Fan et al., 2003; Ran et al., 2008). 
Relaxation times T1 were determined by collecting 8 points with delays of 10, 280, 
700, 1000, 1100, 1250, and 1400 ms using a recycle delay of 1 s. Relaxation times 
T1ρ were measured by collecting seven points with delays of 1, 10, 20, 30, 40, 45, 
and 52 ms using a spin-lock power of 1.6 kHz, a 2.5-s recycle delay. {1H}-15N steady-
state NOEs were obtained by recording spectra with and without 1H presaturation of a 
duration of 3 s plus a relaxation delay of 6 s at 800 MHz.  
Relaxation times were fitted as single exponential decays to peak height data. 
Spin-spin relaxation time T2 was calculated from T1ρ and T1 according to equation: 
1
ܶ1ߩ ൌ
sin ߠ ൈ sin ߠ
ܶ1 ൅
cos ߠ ൈ cos ߠ
ܶ2  
Where θ=atan(Δω/ω1) and Δω, ω1 are the resonance offset and spin-lock field 
strength, respectively (Fan et al., 2003) . NMR relaxation data were analyzed by 
“Model-Free” formulism with protein dynamics software suites (Fushman et al., 
1997). According to Abragam, 1961, relaxation of protonated heteronuclei is 
dominated by the dipolar interaction with the directly attached 1H spin and by the 
chemical shift anisotropy mechanism. Relaxation parameters are given by: 
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ܴଵ ൌ ݀ଶ 4ൗ ሾܬሺ߱ு െ ߱௑ሻ ൅ 3ܬሺ߱௑ሻ ൅ 6ܬሺ߱ு ൅ ߱௑ሻሿ ൅ ܿଶܬሺ߱௑ሻ 
ܴଶ ൌ ൭݀ଶ 8ൗ ൱ ሾ4ܬሺ0ሻ ൅ ܬሺ߱ு െ ߱௑ሻ ൅ 3ܬሺ߱௑ሻ ൅ 6ሺܬ߱ுሻ ൅ 6ܬሺ߱ு ൅ ߱௑ሻሿ 
൅ሺܿଶ 6ൗ ሻሾ4ܬሺ0ሻ ൅ 3ܬሺ߱௑ሻሿ ൅ ܴ௘௫ 
ܱܰܧ ൌ 1 ൅ ሺ݀ଶ 4ܴଵ⁄ ሻሺߛ௑ ߛு⁄ ሻሾ6ܬሺ߱ு ൅ ߱௑ሻ െ ܬሺ߱ு െ ߱௑ሻሿ 
In which ݀ ൌ ߤ଴݄ߛ௑ߛு ൏ ݎ௑ுିଷ ൐ 8ߨଶ⁄ , ܿ ൌ ߱௑∆ߪ √3⁄ , ߤ଴  is the permeability of 
free space; h is Planck’s constant; ߛ௑ ߛு are the gyromagnetic ratios of 1H and the X 
spin (X=13C or 15N) respectively; ߛ௑ு  is the X-H bond length; ߱ு  and ߱௑  are the 
Larmor frequencies of 1H and X spins, respectively; and Δσ is the chemical shift 
anisotropy of the X spin. 
The Model-Free formalism, as described by Lipari and Szabo, and extended by 
Clore and co-workers, determines the amplitudes and time scales of the 
intramolecular motions by modeling the spectral density function, J(ω), as 
ܬሺ߱ሻ ൌ 25 ሾ
ܵଶ߬௠
1 ൅ ሺ߱߬௠ሻଶ ൅
ሺ ௙ܵଶ െ ܵଶሻ߬




1 ൅ ሺ߱߬௠ሻଶ ൅
ሺ1 െ ܵ௦ଶሻ߬
1 ൅ ሺ߱߬ሻଶ ሿ 
In which, ߬ ൌ ߬௦߬௠ ሺ߬௦ ൅ ߬௠ሻ⁄ , ߬௠ is the isotropic rotational correlation time of the 
molecule, ߬௦ is the effective correlation tile for internal motions, ܵଶ ൌ ௙ܵଶܵ௦ଶ is the 
square of the generalized order parameter characterizing the amplitude of the internal 
motions, and ௙ܵଶ  and ܵ௦ଶ  are the squares of the order parameters for the internal 
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motions on the fast and slow time scales, respectively. Generalized order parameters 
represent motions that are described by dynamics on the ns-ps time scale, with values 
ranging from zero for isotropic internal motions to unity for completely restricted 
motion in a molecular reference frame.  
In order to allow for diverse protein dynamics, several forms of the spectral density 
function, based on various models of the local motion, were utilized. Including the 
original Lipari&Szabo approach, assuming fast local motion characterized by the 
parameters S2 and τloc; extended model-free treatment, including both fast 
( ௙ܵ௔௦௧ଶ, ߬௙௔௦௧ ) and slow (ܵ௦௟௢௪ଶ, ߬௦௟௢௪ )reorientations for the NH bond ( ߬௙௔௦௧ ا
߬௦௟௢௪ ൏ ߬௖); and could also allow for slow, milli- to microsecond dynamics resulting 
in a conformational exchange contribution, Rex, to the linewidth. The first software 
used to do modelfree analysis was developed by Palmer A. G., but in this paper, 
analysis of relaxation data was performed by using software DYNAMICS (Fushman 
et al., 1997; Hall and Fushman, 2003). 
The overall rotational diffusion tensors as well as total correlation time (τc) of the 
EphA4 LBD was determined by ROTDIF (Walker et al., 2004; Fushman et al., 1997). 
Isotropic, axially-symmetric and fully anisotropic models for the overall motion were 
used and then compared. According to the illustration of ROTDIF, fully anisotropic 
model was finally selected because of smallest Ch2/df value. 
 
2.4   Crystallization, data collection, and structure determination 
The EphA4 ligand-binding domain was prepared at a concentration of 12 mg/ml 
and crystallized by setting up 2 μl hanging drops at room temperature in well 
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containing the reservoir solution (18% PEG 4000, 11% isopropanol and 0.1 M Hepes 
at pH 7.5). Rock-like crystals formed after 4 days and dehydration of the crystals was 
subsequently performed by moving the coverslips to a new well containing 
dehydration buffer (18% PEG 4000, 11% isopropanol, 10% glycol and 0.1 M Hepes 
at pH 7.5).  
The X-ray diffraction images for a single crystal were collected by using an in-
house Rigaku/MSC FR-E X-ray generator with an R-AXIS IV++ imaging plate 
detector at the Biopolis shared-equipment facility. The crystal was protected by the 
cryoprotectant. The data were indexed and scaled using the program d*Trek. After an 
all-space-group search, the crystals were identified as belonging to the space group P1 
with 8 EphA4 molecules per asymmetric unit. The Matthews coefficient was 
calculated as 2.98 with 58.78% solvent constant and 2.53 with 51.32% solvent 
constant respectively by CCP4 software package (Collaborative Computational 
Project, No. 4, 1994) 
The structure was determined through the molecular replacement with the search 
model of the EphA4 ligand-binding domain generated by using our previously-
determined free EphA4 structure (3CKH) (Qin et al, 2008). This model was 
completed by manual fitting using the program COOT. The refinement was carried 
out by program Refmac (Collaborative computational project, No. 4. 1994. The final 
structure was analyzed by PROCHECK (Laskowski, R. A. et al, 1993). All the figures 
were prepared using the Pymol molecular graphics system (W. L. DeLano, DeLano 
Scientific LLC, San Carlos, CA).     
    The EphA4-ephrin-B2 complex was prepared at a concentration of 10 mg/ml and 
crystallized by setting up 2 μL hanging drops at room temperature in a well containing 
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the reservoir solution (23.5% PEG 4000, and 0.1 M Tris, 0.2 M MgCl2, pH 7.5). 
Rock-like crystals formed after 7 days. X-ray diffraction images for a single crystal 
were collected by using an in-house Bruker X8 Proteum X-ray generator with a CCD 
detector. The crystal was protected by cryoprotectant (23.5% PEG 4000, and 0.1 M 
Tris, 0.2 M MgCl2, pH 7.5). The data were indexed and scaled using the program 
HKL2000 (Otwinowski & Minor, 1997). After an all-space-group search, the crystal 
was identified as belonging to the space group P2(1) with a=54.651, b=48.711, and 
c=64.469 with one complex molecule per asymmetric unit. The Matthews coefficient 
was 2.22 with 44.51% solvent constant.  
The model of the EphA4 LBD was generated by the program Phaser (McCoy et al, 
2005) from the CCP4 suite (Collaborative Computational Project, 23, 1994) using our 
previously-determined free EphA4 structure (3CKH) as a search model through the 
molecular replacement method (Qin et al, 2008). After determining the EphA4 
structure, EphA4 was fixed and the model of ephrin-B2 was generated by the CCP4 
suite using a previously determined ephrin-B2 structure (1KYG) as search model. The 
two models were subsequently combined as search model to find an initial model of 
the EphA4-ephrin-B2 complex using the program molrep. This model was completed 
by manual fitting using the program COOT (Emsley and Cowtan, 2004) and refined 
using the program CNS (Brunger et al, 1998) for many iterations. The final structure 
was analyzed by PROCHECK (Laskowski et al, 1993) and the details of the data 
collection and refinement statistics are shown in Supplementary Table S1. All the 
figures were prepared using the PyMOL molecular graphics system (W. L. DeLano, 




2.5   CD experiments and sample preparation 
    CD samples were prepared by dissolving proteins and peptides in 5 mM phosphate 
buffer at pH 6.2 with 0.02% (W/V) sodium azine. Eph and ephrin samples were kept 
in 10mM phosphate buffer at pH 6.3 with 0.02% (W/V) sodium azine. CD 
experiments were performed on a Jasco J-810 spectropolarimeter equipped with a 
thermal controller. The far-UV CD spectra of the WW domains and Eph/ephrin were 
collected at a protein concentration of ~20 μM at 25ºC, using 1 mm path length 
cuvette with a 0.1 nm spectral resolution. Data from three independent scans were 
added and averaged. To assess the stability of WW domains, thermal unfolding was 
carried out. CD signal at 230nm was monitored as the temperature increased from 5 
ºC to 95 ºC. The secondary structure fraction was analyzed by use of CONTINLL 
program (lamar.colostate.edu/~sreeram/CDPro/ReadMe.htm). 
 
2.6   Isothermal Titration Calorimetry and NMR titration 
ITC titration to study protein interaction 
    All isothermal titration calorimetric (ITC) experiments were performed using a 
Microcal VP ITC machine. Protein was placed in a 1.8 ml sample cell, while ligands 
were loaded into a 300 µL syringe. A control experiment with the same parameter 
setting was also performed to subtract the contribution of the ligand dilution. The 
titration data after subtracting the results of the control experiment were fitted using 
the built-in software ORIGIN to obtain thermodynamic binding parameters. 
NMR characterization of binding 
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    To characterize binding interactions between proteins and ligands, two dimensional 
1H-15N HSQC spectra of the 15N-labeled proteins were acquired at a protein 
concentration of ~100 µM in the absence or presence of the ligands at different molar 
ratios. By superimposing the HSQC spectra of the 15N-labeled free protein and 
mixture of protein and ligand, the shifted HSQC peaks could be identified. The degree 
of binding-induced perturbation was represented by an integrated chemical shift index 
calculated by the formula [(1H)2 + (15N/4)2]1/2 ppm (Liu J. et al, 2006). 
 
2.7   Docking and modelling 
Molecular docking of WW4 and Nogo-A (650-666) was performed by using 
software Haddock2.0 (High Ambiguity Driven protein-protein Docking, 
http://www.nmr.chem.uu.nl/haddock/), which makes use of chemical-shift 
perturbation data to derive the docking while allowing various degrees of flexibility. 
The docking procedure was performed by three steps. First, randomization and rigid 
body energy minimization; Second, semi-flexible simulated annealing; Third, flexible 
explicit solvent refinement. 
According to Haddock definition, the solution accessible residues which has larger 
chemical shift perturbation value (larger than 2 times average value) were set as 
active residues, and all the residues close to the active residues, and solvent accessible 
were set as passive residues. 
    The PDB file of Nogo-A (650-666) was generated by CNS from its sequence. In 
order to achieve reasonable docking result, all the residues that did not interact with 
WW4 were removed. 
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    1000 structures were generated during the rigid body docking, and the best 100 
structures were selected for semi-flexible simulated annealing. The best 20 structures 
were selected for further refinement in explicit water. The overall HADDOCK score 
used at the various stages to rank and select solutions was calculated as a weighted 
sum of different terms (rigid body stage: 0.01×Evdw+1.0×Eelec+0.01×EAIR-
0.01×BSA+1.0×Edesolv; semiflexible refinement: 1.0×Evdw+1.0×Eelec+0.1×EAIR-
0.01×BSA+1.0×Edesolv; water-refinement: 1.0×Evdw + 0.2×Eelec 
+0.1×EAIR+1.0×Edesolv). Here the subscripts are: vdw the van der Waals energy, 
Elec the electrostatic energy, BSA the buried surface area, AIR the AIR energy 
Table1.2:   Active residues and flexible regions used in docking of WW domain and 
nogo-A polyproline peptide 
Segid Active residues Fully flexible regions 
A(WW4) W9-I11, T28-T30 N1-L5, P34-S39 
B(Nogo-A(650-666)) E652-E661 E652-E661 
 
   Docking solutions were ranked based on the average HADDOCK score calculated 
from top solutions. The best 10 solutions were provided as HADDOCK complex 
structure model. 
    The models of the EphA4 ligand-binding domains in complex with two 
antagonistic molecules were constructed by use of the HADDOCK 1.3 in combination 
with CNS, which is the previous version of HADDOCK2.0. The docking procedure 
was also performed by three steps: first, randomization and rigid body energy 
minimization; second, semi-flexible simulated annealing; third, flexible explicit 
solvent refinement.  
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    To conduct the docking, several invisible residues over the loop regions were added 
to the EphA4 crystal structures by COOT (Emsley, P. et al, 2004) and then the 
obtained structures were subjected to several rounds of energy minimization by 
PHENIX (Adams, P.D. et al, 2002). Subsequently, hydrogen atoms were added to the 
structures by use of the CNS protocol. On the other hand, the geometric coordinates 
and parameters for the two small molecules were generated and energy-minimized by 
the on-line PRODRG server (http://davapc1.bioch.dundee.ac.uk/prodrg/).  
     All EphA4 residues with a chemical shift perturbation greater than the threshold 
value of 0.08 (2.5 times of the standard deviation) were set to be “active” residues 
while neighbors of active residues were defined as ‘‘passive residues’’ according to 
HADDOCK definition. These active residues included Gln43 on the E β-strand, 
Ile31-Met32 and Ile39 on the D-E loop, and Asp123 and Ile131-Gly132 on the J-K 
loop. Furthermore, all residues with heteronuclear NOE intensities of less than 0.7 
were found to be located on the N- and C- termini, or on the loops, and thus set to be 
“fully-flexible” during the molecular docking. One thousand structures were 
generated during the rigid body docking, and the best 50 structures were selected for 
semi-flexible simulated annealing, followed by water refinement. Three structures 



























































3.1.1   Identification of WWP1 as a novel binding partner for Nogo-A 
GST fused Nogo-A specific fragment (567-774) was used as bait in a phage display 
screening. The screening was performed on a human brain cDNA library displayed by 
a T7 phage vector for five rounds of affinity selection. The enrichment after each 
round of selection was analyzed by performing PCR using T7 primers. A single PCR 
product was clearly emerging after 3rd round of selection. The phages display of this 
specific protein become dominant in the 4th and 5th selection. Sequencing of this PCR 
product revealed that this cDNA encoded a WWP1 fragment containing residues 252– 
388. Examination of WWP1 fragment from phage display shows that this fragment 
contains WW domain, which has been extensively documented to bind to proline 
riched consensus sequence with the motif PPxY. Nogo-A fragment contains PPPY 
motif (656-659), thus, we believed that Nogo-A fragment interacts with WWP1 
through WW domain via PPPY motif. The mutation of Y→A totally abolished the 
binding between WWP1 and Nogo-A, which confirmed our hypothesis. WWP1 
contains four WW domains, as well as a long loop from residue 346 to 531, as shown 
in figure 3.1. To investigate the binding mechanism between WWP1 and Nogo-A, we 
prepared the whole WW domain fragment (346-531), called fWW protein, and four 
isolated WW domain (WW1, WW2, WW3 and WW4 corresponding to WWP1 
residues 346-385, 380-417, 453-491, and 494-531 respectively), and proline rich 






















3.1.2   Preliminary CD and NMR characterization 
    The secondary structure of fWW protein was first assessed by far-UV CD 
spectroscopy, as seen in Figure3.2a, the fragment had a positive CD signal at ~230nm, 
but negative signal at ~ 190nm, indicating that the fWW protein consists of the β-turn 
secondary structure, together with some loops. Secondary structure prediction in 
Table 3.1 also confirms this observation. We have prepared 15N isotope-labeled 
fWW protein and subsequently acquired its 1H-15N HSQC spectrum. The fWW 
protein had a relatively dispersed HSQC spectrum, with some peaks even located at 
׽9.5 ppm (Figure 3.2b). However, only ׽80 resonance peaks could be detected in the 
spectrum, much fewer than its number of residues (186). In particular, of these peaks, 
׽40 had very strong intensities while the rest had much weaker intensities. This 
observation implies that the strong HSQC peaks may result from the ׽40-residue 
linker region between the second and third WW domains which might be highly 
unstructured. Nevertheless, as seen in Figure 3.2b, upon addition of the Nogo-A(650-
666) peptide, many HSQC peaks of the fWW protein shifted significantly, indicating 
that it was able to interact with Nogo-A. Unfortunately, due to the very limited 
manifestation of the HSQC peaks as well as a strong tendency to aggregate at a high 
concentration, detailed NMR study is not feasible for the fWW protein. However, as 
presented in panels c and d of Figure 3.2 and Table 3.2, the thermodynamic 
parameters for the binding of fWW to the Nogo-A peptide were successfully obtained 
by using the ITC titration. Interestingly, the fWW protein containing all four WW 
domains is capable of binding to Nogo-A with a dissociation constant Kd of 1.68 μM. 
The structural properties of the four isolated WW domains were also assessed by 
far-UV CD spectroscopy.  As shown in Figure 3.2a, all four WW domains had a 
positive CD signal at ~230 and a negative one at ~208 nm, indicating that all of them 
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possessed β-turn/sheet secondary structures, in complete agreement with the classic 













To visualize structural properties of four isolated WW domains by NMR 
spectroscopy, all proteins were 15N-isotope-labelled and purified by HPLC. 
Subsequently, two-dimensional 1H-15N HSQC spectra were collected on an 800 MHz 
NMR spectrometer. Interestingly, based on their HSQC spectra it appeared that four 
WW domains owned very different structural features.  WW1 and WW2 were only 
partially-folded which had narrowly-dispersed HSQC spectra with only about half of 
the resonance peaks detectable (Figure 3.3a-3.3b).  On the other hand, as seen in 
Figure 3.2   Structural and binding characterization of the fWW protein. (a) Far-UV
CD spectra of fWW and four isolated WW domains at protein concentrations of 20
μM in 5 mM phosphate buffer (pH 6.2) at 25 °C. (b) Superimposition of the HSQC
spectra of the 15Nlabeled fWW protein in the absence (blue) and presence (red) of
Nogo-A(650-666) at a molar ratio of 1:4 (fWW:peptide). Spectra were acquired in 5
mM phosphate buffer (pH 6.2) at 25oC on an 800 MHz Bruker NMR spectrometer. (c)
ITC titration profiles of the binding reaction of the fWW protein with Nogo-A (650-
666). (d) Integrated values for reaction heats with subtraction of the corresponding
blank results normalized by the amount of ligand injected vs the Nogo-A:fWW molar
ratio. The detailed conditions and setting of the ITC experiments are presented in
Materials and Methods as well as Table 3.2.
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Figure 3.3d, WW4 was the best-folded with uniform HSQC peak intensities in a well-
dispersed spectrum (~3 ppm for 1H and 26 ppm for 15N dimensions).  With regard to 
WW3, although it was folded as evident from its well-dispersed HSQC spectrum 
(Figure 3.3c), its peak intensities were not uniform, indicating that some regions 














Figure 3.3 Binding of four 15N-labeled WW domains with Nogo-A (650-666). 
Superimposition of the HSQC spectra of 15N-labeled WW1(a), WW2(b), WW3(c), 
and WW4(d) in the absence (blue) and presence (red) of Nogo-A(650-666) at a molar 
ratio of 1:4 (WW:peptide). All spectra were recorded in a 5 mMphosphate buffer (pH 
6.2) at 25 °C on an 800 MHz Bruker NMR spectrometer. The doublets of some 
HSQC peaks of the complexed WW3 domain are indicated. 
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    The binding interactions between WW domains and the Nogo-A (650-666) peptide 
were assessed by NMR HSQC titrations.  Very interestingly, although as shown 
above, the fWW protein and four WW domains had very-different HSQC spectra, 
addition of Nogo-A (650-666) induced dramatic HSQC-peak shifts for all of them 
(Figure 3.3), indicating that all of them were able to bind the Nogo-A (650-666) 
peptide. In particular, for WW1 and WW2 domains, the introduction of Nogo-A (650-
666) resulted in manifestation of HSQC peaks for almost all non-proline residues, 
clearly indicating that upon binding, the WW1 and WW2 domains underwent 
significant conformational changes from partially-folded to folded states. The addition 
of Nogo-A to fWW protein did not induce dramatic chemical shift changes to the 
residues with strong intensity. This might because the residues with strong intensity 
may locate at random coil regions, which had weak interaction with the peptide. 
 
3.1.3   ITC measurements of binding parameters  
    To quantitatively characterize binding interactions between WW domains and 
Nogo-A (650-666), isothermal calorimetric titrations were conducted to measure their 
thermodynamic binding constants.  The raw titration data were shown in Figure 3.4 
while binding parameters obtained by data-fitting were presented in Table 3.2.  Very 
strikingly, although fWW protein and four WW domains possessed very differential 
structural characteristics, they held very similar affinities to the Nogo-A (650-666) 
peptide, with dissociation constants ranging from ~1.0 to 4 µM, which could be 
ranked within a high affinity category among previously-documented WW-ligand 
interactions70. From the ITC profile of fWW protein (figure 3.2C), the four WW 
domains seemed bind to Nogo-A peptide as a whole protein without binding 
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preference to different WW domains. This phenomenon may due to the similar 
dissociation constants of four WW domains. They cooperate with each other than 
compete to each other in signalling transduction.  
 
Figure 3.4   ITC characterization. ITC titration profiles of the binding reactions of the 
WW1 (a), WW2 (c), WW3 (e), and WW4 (g) domains with Nogo-A(650-666). 
Integrated values for reaction heats with subtraction of the corresponding blank 
results normalized by the amount of ligand injected vs the Nogo-A:WW1 (b), Nogo-
A:WW2 (d), Nogo-A:WW3 (f), and Nogo-A:WW4 (h) molar ratio. The detailed 
conditions and settings of the ITC experiments are presented in Materials and 




3.1.4   NMR characterization of binding interactions 
    The detailed binding of Nogo-A (650-666) to WW domains was characterized by 
monitoring the HSQC peak shifts of the peptide induced by adding different WW 
domains. Interestingly, four WW domains induced very similar shift patterns for 
HSQC peaks of Nogo-A (650-666), indicating that they interacted with Nogo-A in a 
similar manner.  As exemplified in Figure 3.5, upon adding WW4 domain, the HSQC 
peaks of the characteristic residue Tyr659 with its neighbouring residue Glu660 
totally disappeared, indicating the binding would induce dramatic conformational 
exchanges over this region on the μs-ms time scale.  It is worthwhile to note that 
residues Glu652, Glu654 and Asn655 N-terminal to the PPPY motif also underwent 
significant shifts, indicating that these residues might also play an important role in 













Figure 3.5 Binding of 15N-labeled Nogo-A(650-666) with the WW4 domain. (a) 
Superimposition of the HSQC spectra of the 15N-labeled Nogo-A(650-666) peptide 
in the absence (black) and presence (red) of the WW4 domain at a 1:4 peptide:WW4 
molar ratio. All spectra were recorded in a 5 mM phosphate buffer (pH 6.2) at 25oC 
on an 800 MHz NMR spectrometer. The sequential assignments of Nogo-A(650-666) 
were made by analyzing heteronuclear HSQC-TOCSY and HSQC-NOESY spectra. 
The sequence of Nogo-A(650-666) was included, and the two residues (Tyr659 and 
Glu660) with HSQC peaks that completely disappeared upon binding are labeled in 
red. Residues Glu652, Glu654, and Asn655 with significant peak shifts upon binding 
are labeled in cyan. (b) Residue-specific chemical shift difference (CSD) of Nogo-A 
(650-666) induced by binding to the WW4 domain. The bar values were calculated 
from the shifts observed in Figure 5a using the formula described in Materials and 













3.1.5   Three dimensional structure and binding interface of the WW4 domain 
 It will be more straightforward if we determine the 3D structure of fWW 
protein and Nogo-A peptide. However, from the above NMR and CD results, fWW 
protein was identified to possess poor structure, making the structure determination 
infeasible. Moreover, out of four WW domains, WW1, WW2 and WW3 had 
extensive conformational exchanges on μs-ms time scale, thus not suitable for 
determination of three-dimensional structure. On the other hand, we also attempted to 
determine the WW structure complexed with Nogo-A (650-666) but failed because 
the binding induced severe conformational exchanges on μs-ms time scale as 
exemplified in Figure 3.3.  Therefore, in this study we decided to determine the 
solution structure of WW4 and subsequently derived its binding interface with Nogo-
A (650-666) by NMR HSQC titration.  Figure 3.6a showed the 1H-15N HSQC spectra 
of the WW4 domain in the absence and in the presence of Nogo-A (650-666) at a 
ratio of 1:4 (WW4/peptide) while Figure 3.6b presented the residue-specific shifts of 
the WW4 HSQC peaks upon binding to the peptide. Interestingly, the significantly-
perturbed residues (with shift index >0.2) were located over two regions, one over 
Trp9-Glu10-Ile11 and another over Thr28-Thr29-Thr30.  This result is overall in 
agreement with previous observations that two discrete WW regions were mainly 
responsible for binding to the ligand, one centralized around the first Trp residue and 
another around the second Trp residue.  However, it is very interesting to note that in 
WW4, the most-perturbed residues were centralized around Thr28-Thr29-Thr30 but 






Figure3.6 Binding of the 15N-labeled WW4 domain with Nogo-A (650-666). (a) 
Superimposition of the HSQC spectra of the 15Nlabeled WW4 domain in the absence 
(blue) and presence (red) of Nogo-A (650-666) at a 1:4 WW4:peptide molar ratio. All 
spectra were acquired in 5 mM phosphate buffer (pH 6.2) at 25oC on an 800 MHz 
NMR spectrometer. The sequential assignments of WW4 were made by analyzing 
heteronuclear HSQC-TOCSY and HSQC-NOESY spectra. The residues with 
significant peak shifts upon binding are labelled in the spectra. (b) Residue-specific 
chemical shift difference (CSD) of WW4 induced by binding to Nogo-A (650-666). 
The bar values were calculated from the shifts observed in Figure 3.6A using the 
formula described in Materials and Methods. Red was used for coloring residues with 
changes larger than 0.6, pink for residues with changes larger than 0.2 but smaller 
than 0.6 if on the third β-strand, and green for residues on the first β-strand. 
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   By using experimental NMR distance and dihedral angle constraints, the three-
dimensional structure of the WW4 domain was determined. Figure 3.7a shows the 10 
solution structures with the lowest target functions while Table 3.3 presents their 
structural statistics. As seen in Figure 3.7a, the WW4 domain adopts an antiparallel 
three-stranded β-sheet fold common to all WW domains94-96, with the first β-strand 
over residues Gly8-Tyr13, second over Arg19-His24 and third from Thr28-Phe31 
respectively. Interestingly, in the WWP1 WW4 domain there is a short C-terminal 3-
10 helix formed over residues Pro34-Asn36 which is not conserved in the classic WW 
fold. In the 10 WW4 solution structures, the secondary structure regions are well-
defined, with rms deviations of 1.37 Å for all atoms, 1.12 Å for the heavy atoms and 
0.25 Å for the backbone atoms respectively.  
Based on the HSQC titration data for both WW4 domain and Nogo-A peptide, we 
have constructed the model of the WW4 domain in complex with the Nogo-A peptide 
by the well-established HADDOCK 2.0 program with the best structural solution 
shown in Figures 3.7b and 3.7c. As seen in Figures 3.7a and 3.7b, the Nogo-A peptide 
binds to the WWP1 WW4 domain in a manner very similar to those previously 
reported for other WW-PPxY complexes. Briefly, the major WW4 residues in contact 
with the Nogo-A peptides include two aromatic residues Tyr20 and Phe31, Val22, 
His24 and Thr29 which are highly conserved and thus thought to be common residues 
critical for the ligand binding. On the other hand, the residue Glu10 located in the first 
β-strand also has a close contact with Tyr659 sidechain. Interestingly, in WW 
domains such as from Yap and Rsp proteins, the position corresponding to Glu10 is 
occupied by the negatively-charged Glu residue. By contrast, in some other WW 
domains from Ykb2, Db10 and Yfx1 proteins, this position resides in a positively-
charged Lys residue. As seen in Figure 3.6, upon binding to Nogo-A, Glu10 in the 
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WW4 domain is also significantly perturbed, implying that it may play an important 
role in the binding of the WWP1 WW4 domain to Nogo-A. The result that the 
mutation of Tyr659 completely abolished the binding ability of the Nogo-A peptide 
strongly highlights the critical role of Tyr659 in binding with the WWP1 WW4 
domain. Indeed, as seen in Figure 3.7c, the Tyr659 sidechain deeply inserts into a 
pocket formed by the residues Glu10 and His24, thus explaining why the WW4 
residue Glu10 was significantly perturbed by binding to the Nogo-A peptide (Figure 
6). Furthermore, in the complex model, the Nogo-A residue Pro656 has a close 
contact with the WW4 residue Thr29, thus rationalizing the observation that upon 
binding to the Nogo-A peptide, the residues centralizing Thr28-Thr29-Thr30 were 







Figure 3.7 Structures of the free and complexed WW4 domains. (a) Superimposition 
of the 10 selected NMR structures of the WW4 domain having the lowest target 
functions in ribbon mode. (b) Best docking solution of the WW4 domain (gray) in 
complex with the Nogo-A peptide (yellow). The side chains of the binding-important 
residues are displayed as sticks and labeled for both the WW4 domain and Nogo-A 
peptide. (c) Surface representation of the WW4 domain in complex with the Nogo-A 
peptide in stick mode. The binding-perturbed WW4 residues are colored as in Figure 




3.1.6   Discussion 
    Nogo-A is a multifunctional protein which has been implicated in a variety of 
diverse and important biological processes, including inhibition of neural regeneration 
(Schwab ME et al, 1988), participation in ER shaping (Voeltz G.K. et al, 2006), and 
stabilization of neuromuscular junction (Jokic N. et al, 2006). In particular, changes in 
the intracellular Nogo-A protein level have been directly associated with stroke (Li S. 
et al, 2006) as well as other neurodegenerative diseases such as amyotrophic lateral 
sclerosis (ALS) (Jokic N. et al, 2005) and Alzheimer’s disease (Gil V. et al, 2006). 
These observations clearly indicate that the Nogo-A protein level represents a critical 
factor in regulation of its functions. However, so far how the Nogo-A protein level is 
regulated in cells remains unknown. On the other hand, Nogo-A is extensively 
believed to interact with many other proteins, and consequently, identification of such 
novel binding partners holds key implications in understanding the functional roles of 
Nogo-A as well as designing molecules of therapeutic interest. 
    In this study, we first successfully identified WWP1 to be a novel binding partner 
of Nogo-A. In particular, our results demonstrate that WWP1 forms a complex with 
the endogenous Nogo-A both in vitro and in vivo. WWP1 belongs to the E3 ubiquitin 
ligase family which is the critical component that provides specificity to the Ub 
system. More specifically WWP1 utilizes its WW modular domains to specifically 
bind to the PPxY motif in the substrate and consequently promotes ligation of 
ubiquitin to the substrate. Currently, we have obtained the in vivo results revealing 
that WWP1 indeed binds Nogo-A to promote Nogo-A ubiquitination, thus regulating 
the Nogo-A protein level. Given the critical role of the Nogo-A protein level in 
various human diseases, the Nogo-A-WWP1 interaction interface may represent a 
promising target for developing molecules of medical interest. So far, no structural 
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study has been reported for the WWP1 WW domains. Given the crucial role of the 
interaction between the WWP1 WW domains and PPxY motif in its substrates, we 
further conducted extensive investigations on all four WWP1 WW domains as well as 
their interactions with the Nogo-A(650-666) peptide carrying the only Nogo-A PPxY 
motif by using ITC, CD, and NMR spectroscopy. The results show that despite 
containing a large unstructured region in the 186-residue fWW protein consisting of 
all four WW domains, it is able to bind to the Nogo-A (650-666) peptide with a high 
affinity, with a Kd of 1.68μM. On the other hand, surprisingly, the CD and NMR 
characterization reveals that four isolated WWP1 WW domains have differential 
structural properties. While the fourth WW domain is well-folded, the first and second 
WW domains undergo extensive conformational exchanges on the microsecond to 
millisecond time scale, likely due to a slight unfolding or/and a slight dynamic 
aggregation, which causes many HSQC peaks to be undetectable. Nevertheless, as 
revealed by ITC measurements, all four WWP1 WW domains are capable of binding 
to Nogo-A(650-666) with similar affinities, with Kd values ranging from 1.03 to 3.85 
μM, which can be ranked within a high-affinity category among previously 
documented WW-ligand interactions. Very interestingly, as shown by NMR 
characterization, the partially folded WW1 and WW2 domains suddenly undergo 
significant conformational transitions to become well-structured upon binding to 
Nogo-A (650-666). This phenomenon is rarely observed for the native WW domains, 
and previously, only one engineered Trp17-to-Phe mutant of the YAP WW domain 
was found to be partially unfolded in the free state but became structured upon 
binding to the PPxY ligand. Further structure determination of the best-folded WW4 
domain by NMR spectroscopy shows that it adopts a common WW fold with an 
antiparallel three-stranded β-sheet, with an additional C-terminal 310-helix. Detailed 
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HSQC titrations indicate that the Nogo-A binding interface of the WW4 domain is 
mostly constituted by residues centralized over the Thr28-Thr29-Thr30 sequence on 
the third β-strand and over the Trp9-Glu10-Ile11 sequence on the first strand. 
Furthermore, the complex model generated from molecular docking suggests that the 
Nogo-A peptide binds to the WW4 domain in a mode very similar to those previously 
reported. More importantly, the complex model rationalizes the HSQC titration results 
as well as the mutation result that Tyr665 of Nogo-A (650-666) is absolutely 
indispensable for the binding to the WW4 domain. Recently, we have demonstrated 
that the whole 1016-residue N-terminus of human Nogo-A was intrinsically 
unstructured. Therefore, in vivo this WW-binding motif of Nogo-A might be already 
accessible to WWP1 without needing to be further unfolded. 
    In conclusion, we have identified WWP1, an E3 ubiquitin ligase, as a novel binding 
partner for Nogo-A which may regulate the Nogo-A protein level in vivo. With 
consideration that the protein level of Nogo-A is a key factor regulating its functions, 
and in particular correlated with human diseases, the interaction interface between the 
WWP1 WW domains and the Nogo-A PPPY motif might represent a promising target 
for design of molecules of significant medical interest. In this regard, this study also 








Table3.1  Secondary Structure Fraction Prediction Based on far-UV CD Spectrum 
 fWW WW1 WW2 WW3 WW4 
α-Helix 0.059 0.004 0.004 0.034 0.047 
β-strand 0.106 0.427 0.430 0.413 0.433 
β-turn 0.466 0.225 0.212 0.321 0.167 
Random 
coil 








































Table 3.3 Structural statistics for 10 selected NMR structures of the WW4 domain 
Experimental constraints for structure calculation 
NOE restraints 
                              Total      263 
                              Intra residue                                              119 
                              Sequential                                     49 
                              Medium                                               17 
                              Long-range                                           78 
                             Dihedral angle constraints                                     54 
CYANA target function                                  0.63 ± 0.035 
                            Distance violations (>0.20 Å)     0 
                            Dihedral angle violations (>5º)   0 
Ramachandran statistics (%) 
                            Most favored:                                   71.0 
                            Additionally allowed:                                       22.6 
                            Generously allowed:                             6.5 
                            Disallowed:                                    0.0 
Root mean square deviation (Å)                Secondary structure regions (7-14,18-
24,27-32) 
                           All atoms                   1.28 
                           Heavy atoms               1.04 
















3.2   Sixteen Structures in Two Crystals Reflect the Highly Dynamic 













Two apo EphA4 receptor crystals were obtained in our lab and their structures were 
determined at 2.4Å and 2.9 Å, respectively.  What make these crystals unique is that 
there are 8 EphA4 molecules in one asymmetric unit (AU). Previous works of Eph 
receptors show that complex structure of EphB2 and ephrinB2 (Himenan et al, 2001), 
EphA2 and ephrinA1 (Himenan et al, 2009) will form complex clusters in one single 
asymmetric unit, but this kind of protein cluster has never been observed in free Eph 
receptors. Comparison of these structures showed that even in a single AU, with the 
presence of packing force, A-C, D-E, G-H, and J-K loops still could adopt various 
conformations, indicating they are highly flexible. More importantly, both open and 
closed conformations of J-K loop coexist in these structures, indicating that, many 
different conformations coexist over the loop regions, which may be ready for binding 
to different ligands with slight rearrangements. It also should be pointed out that J-K 
loop adopted open conformation only when G-H loop of neighbour EphA4 molecule 
was inserted into the classical binding channel, which may help us to understand more 
on induce and fit mechanism.  
 
3.2.1   16 structures determined from two EphA4 LBD crystals 
We refer these two crystals as crystal1 and crystal2. Crystal1 is determined with 
resolution 2.9 Å, and crystal2 is determined with resolution 2.4 Å. There are 8 
molecules in one asymmetric unit (AU) in both crystals. Therefore, 16 EphA4 ligand 
binding domain structures were captured at the same time. The details of the data 
collection and refinement statistics are shown in Table3.4. The overall topology of 
these EphA4 structures is identical to previous Eph receptor structures. It is composed 
of 11 anti-parallel β-strands organized in jellyroll β-sandwich architecture, with 
several loops with various lengths. Most of the electron density map is complete with 
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side chain, but the map quality of D-E and J-K loops is relatively poor. In some 
regions, only the map of backbone can be traced, which are substituted as poly-A in 
the model built, while in some regions, the map is completely invisible. As shown in 
Figure 3.8, the arrangement of these EphA4 molecules is very complicated. In general, 
they are interacting with the molecules of the same AU or the molecules from 
neighbour AU through polar contacts or hydrophobic interactions. In crystal1, the 
polar contacts are between chain A and G, C and D, E and H, F and H. The 
hydrophobic contacts are between G-H loop and classical binding channel. G-H loop 
of chain D and F inserted into binding channel of chain C and H respectively. There 
are also contacts between the molecules of different AU. The classical binding 
channel of chain A and G were occupied by G-H loop from another AU. In crystal2, 
polar contacts mainly located at G-H, H-I, and part of J-K loops, as well as G and K 
strands.  Chain A interact with chain C and E; chain B interact with chain D, H and F; 
chain C interact with G and E; chain D interact with chain B and F. All the molecules 
in crystal2 adopt closed conformation because their binding channels are left 
unoccupied. There are contacts between different AU, but still no interaction between 
























































3.2.2   Comparison between 16 structures and previous EphA4 structures 
Comparison of these structures shows that except for the loop regions, the regions 
with secondary structure are highly superimposed. The mean global backbone RMSD 
of these structures is 1.48±0.54Å, while mean global heavy atom RMSD is 1.94 ± 
0.54 Å. When only secondary structure regions were considered, the mean global 
backbone RMSD is 0.23±0.07 Å, while mean global heavy atom RMSD is 0.42±0.11 
Å. The loop regions adopted various conformations, showing their high flexibility. 
Figure3.9  Comparison between 16 EphA4 LBD structures. The loops are labelled 







The mean global backbone RMSD of these regions is 2.69±1.04 Å, and the mean 
global heavy atom RMSD is 3.61±1.13 Å (Figure3.9). 
The previous released EphA4 ligands binding domain structures and the structures 
in this paper were compared in Figure3.10. Both free and complex states of EphA4 
ligand binding domain were included. It can be observed that D-E and J-K loops have 
various conformations. Based on the analysis to the released EphA4 LBD structures, 
it could be concluded that J-K loop, the fragment from D123 toN139 (according to the 
sequence of our construct), adopts dramatic different conformations in free and bound 
states (Figure 3.10). Compared with these EphA4 LBD structures, the EphA4 
structures we resolved here could be categorized into two categories. One is free and 
fully closed conformation, which is identical with the conformation of free EphA4 
LBD dimer (3CKH, Qin et al, 2008; 2WO1, Bowden A.T. et al, 2009) (shown in red 
in Figure3.10). The other category has opened J-K loops, which is identical with the 
conformation in EphA4/ephrin complexes (3GXU, Qin et al, 2010; 2WO2, Bowden 
A.T. et al, 2009; 2WO3, Bowden A.T. et al, 2009) (shown in blue in Figure3.10). On 
the other hand, all D-E loops adopt closed conformation, which is identical with the 
conformations of free EphA4 LBD (shown in red in Figure3.10). When we examined 
the interaction between these EphA4 molecules, we found that some G-H loops 
inserted into the classical binding channel of neighbour molecules, thus leading to the 
closed to open states transition of J-K loops. All D-E loops taking closed 
conformation probably because the lacking of polar contacts on D, E strands of 
neighbour molecules. These polar contacts are present between A-C loop, D, E 
strands of EphA4 and C, G, and F strands of ephrinB2 ligands (Figure 3.11), as well 
as other Eph receptors and their ephrin ligands (Himanen et al, 2001; Chrencik J.E. et 
al, 2008; Bowden T.A. et al, 2009; Qin et al, 2009). It should be noticed that the 
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structure with PDB ID 3CKH has similar conformation. 3CKH has two EphA4 LBD 
in one AU, one is fully closed, the other one has opened J-K loop because the G-H 
loop of neighbour molecule is inserted. D-E loop also has closed conformation 
because of lacking polar contacts on D, E strands. Under each category, these loops 
show various conformations, indicating that these loops are highly dynamic. The 
electron density maps of open and closed conformations are shown in Figure3.12. 















Figure3.10 16 EphA4 LBD structures presented here versus open and closed 
conformations in previous publications. In order to have a clear review, two 
structures were selected to compare in each conformation. (a), closed 
conformation, green: two EphA4 LBD structures in this thesis with open 
conformation; red: closed conformation in previous study (Chain B of 2WO1); (b), 
open conformation, green: two EphA4 LBD structures in this thesis with open 






















Figure 3.11 Comparison of the interactions between EphA4/EphA4, and 
EphA4/ephrinB2. (a): Interaction between EphA4 LBD; (b): Interaction between 
EphA4 LBD (green) and ephrinB2 ectodomain (Cyan).  Yellow dashes represent 




















Figure 3.12 Stereo view of J-K and D-E loops built into the simulated annealing 2Fo-
Fc electron density map contoured at 1.0σ. (a). J-K loop in open conformation and its 
electron density map, blue ribbon is from another EphA4 molecule; (b). J-K loop in 
closed conformation and its electron density map; (c). D-E loop and its electron 







3.2.3   Discussion 
Although there are plentiful works on structure study of Eph receptors and 
Eph/ephrin complexes, this is the first time to observe that so many free Eph receptors 
contained in one AU. These two crystals enable us to capture 16 different EphA4 
ligand binding domain structures at the same time. The comparison of these structures 
shows all the loop regions of free EphA4 LBD are flexible. D-E and J-K loops, which 
comprise of the classical binding channel, take various conformations in these 
structures, indicating that even in free EphA4 LBD, various conformations coexist, 
which may be ready to bind different kinds of ephrin ligands with slight 
rearrangement. It is interesting to note that EphB2, the only other Eph receptor which 
can bind both A- and B-class of ephrin ligands, also undergo dramatic conformational 
change over D-E and J-K loops (Y. Goldgur et al, 2009). These observations suggest 
that the ligand promiscuity may directly correlates with the structural flexibility of the 
ligand binding domain of Eph receptors.  
Another interesting result derived from these structures is that, although both open 
and closed conformations coexist over J-K loop, J-K loop adopts open conformation 
only when it is interacted by a G-H loop from other EphA4 LBD.  
Based on these results, the binding between Eph and ephrin does not follow lock 
and key mechanism (Fischer E. 1894), in which two rigid binding partners are of 
complementary shape, whereas, it may be explained by induce and fit mechanism 
(Koshland, D.E. 1958). 
    Comparison of these structures show that both D-E and J-K loops are highly 
dynamic and various conformations are coexist, however, the transition from closed 
to open conformation relies on the interaction from other molecules. For example, D-
E loop keeps closed conformation in all the structures, probably because there is no 
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enough interaction to switch D-E loop from closed to open. Some of J-K loops also 
take closed conformation and there is no molecule interacts with them. However, 
when G-H loop is present, J-K loop will transit from closed to open conformation, just 
like what we observed in these structures. 
Another important point revealed in this paper is that protein dynamics is a 
universal phenomenon and it may be critical in mediating protein-protein interactions. 
Our previous work on ephrinB2 dynamics shows that protein dynamics could be a 
very important complementary aspect to protein structures because most loop regions 
in X-ray structures are rigid, while in fact they are highly dynamic and critical in 
protein-protein interactions (Ran et al, 2008). Compared with X-ray structures, NMR 
structures can reflect protein dynamics because loop regions will have more 
randomized conformations. NMR is also a unique tool to study protein dynamics. It is 
of great interests to solve the NMR structure of Eph receptors and study their 
dynamics in both free and complex states. Those results could be critical to 










Table 3.4   Crystallographic data and refinement statistics for the EphA4 structures 
Data collection Crytal1 Crystal2 
   Wavelength (Ǻ) 1.5418 1.5418 
   Resolution limit (Ǻ) 50-2.9 50-2.4 
   Space group P1 P1 
Cell parameters   
   a, b, c (Å) 53.212, 70.621, 126.985 46.881, 70.030, 123.103 
   α, β, γ ()  90.011, 90.036, 89.999 89.982, 89.972, 89.990 
   Unique reflections 75555 98655 
   Completeness 97.7% 94.6 
   Redundancy 1.1 1.8 
   Linear R-factor 0.082 0.094 
Refinement    
   Resolution range (Å)  25.0-3.0 25.0-2.6 
   R work  0.236 0.237 
   Number of Reflections/test  34290/1816 48082/4071 
   Rfree  0.312 0.262 
   Rmsd bond lengths (Å)  0.013 0.011 
   Rmsd bond angles (deg)  1.613 2.063 
Ramachandran plot    
   Favored, % 75.9 72.9 
   Allowed, % 18.2 21.4 
   Generously allowed, % 3.5 3.2 











3.3  Structure Characterization of EphA4-ephrinB2 Complex Reveals 












3.3.1   Crystal structure of the EphA4-ephrin-B2 complex 
In the present study, we have determined the crystal structure of the EphA4 ligand-
binding domain in complex with the ephrinB2 ectodomain at 2.5 Å resolution with a 
final R-factor of 0.23 (Rfree = 0.285). Details of data collection and refinement 
statistics are summarized in Table 3.5.  
Table 3.5   Crystallographic data and refinement statistics for the EphA4-
ephrinB2 complex structure 
Data collection  
   Wavelength (Ǻ) 1.5418 
   Resolution limit (Ǻ) 50-2.5 
   Space group P2(1) 
Cell parameters  
   a (Å) 54.651 
   b (Å)  48.711 
   c (Å)  64.469 
   α ()  90.000 
   β () 110.434 
   γ () 90.000 
   Unique reflections 11071 
   Completeness 98.8% 
   Redundancy 4.0 
   Linear R-factor 0.144 
Refinement   
   Resolution range (Å)  25.0-2.5 
   R work**  0.23 
   Number of Reflections  11189 
   Rfree***  0.285 
   Rmsd bond lengths (Å)  0.006 
   Rmsd bond angles (deg)  1.457 
Ramachandran plot   
   Favored, % 71.1 
   Allowed, % 25.6 
   Generously allowed, % 2.3 
   Disallowed, % 1.1 
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In the final model, the EphA4-ephrinB2 complex exists as a heterodimer (Figure 
3.13a), consistent with size exclusion FPLC chromatography analysis indicating that 
the two proteins form a 1:1 heterodimer at concentrations of up to 500 μM. Some 
residues were not detectable in the complex due to poor electron density probably 
resulting from local flexibility, including EphA4 G-H loop residues Gly85-Val86-
Met87 and H-I loop residue Arg110 (the numbering is according to the residues in the 
EphA4 construct, as shown in Figure 3.16) as well as ephrinB2 C-D loop residues 
Asp69-Ser70-Lys71-Thr72-Val73-Gly74 and Lys96 (the numbering is according to 
the mouse ephrinB2 sequence for consistency with previously published structures). 
Importantly, however, all EphA4 D-E and J-K loop residues are visible in the 
complex even though some of them were previously undetectable in the free EphA4 
structure (Qin et al, 2008). The overall structure of the EphA4-ephrinB2 complex is 
architecturally similar to those of other Eph-ephrin complexes previously determined, 
with root mean square (RMS) deviations between equivalent Cα positions of 1.56 Å 
for the EphB2-ephrinB2 complex, 1.98 Å for the EphB4-ephrinB2 complex, 1.28 Å 
for the EphB2-ephrinA5 complex, and 2.36 Å for the deposited EphA2-ephrinA1 
complex. However, large structural variations were observed in the EphA4-ephrinB2 
complex as compared with other Eph-ephrin complexes over the loop regions directly 
involved in binding, which include the EphA4 A-C, D-E, G-H and J-K loops (Figure 
3.13b) and the ephrin-B2 G-H loop (Figure 3.13c). 
We previously determined the crystal structure of the EphA4 ligand-binding 
domain in the free state and demonstrated that there are two conformers (designated 
as molecule A and molecule B) in one asymmetric unit (Qin et al, 2008). The two 
EphA4 molecules are almost superimposable over the whole sequence, except for a 
substantial structural difference in the J-K loop. The J-K loop of molecule A does not 
83 
 
have any regular secondary structure while the J-K loop of molecule B contains a 
short β-sheet (Figure3.13b). This difference was attributed to the different packing of 
the two molecules in the neighbouring asymmetric units. Structural comparison of 
EphA4 bound to ephrinB2 with the two free EphA4 molecules reveals that the J-K 
loop of ligand-bound EphA4 is much more similar to that of molecule A than 
molecule B because it does not contain the short β-sheet formed by residues Phe126-
Val129 and Met136-Asn139 (Figure 3.13b). The structure of EphA4 in complex with 
ephrinB2 has RMS deviations of 1.08 Å from the equivalent Cα positions of the free 
EphA4 molecule A, while RMS deviations are 1.13Å from the equivalent Cα 
positions of the unbound EphA4 molecule B. Four EphA4 loops (A-C, D-E, G-H and 
J-K) undergo substantial movements towards ephrinB2 upon binding (Figure 3.13b). 
For example, the Cα atom of Glu14 in the A-C loop shifts by 2.08 Å, the C α atom of 
Pro84 in the G-H loop shifts by 3.06 Å and, strikingly, the Cα atom of Glu34 in the J-
K loop shifts by 10.34Å. EphrinB2 undergoes less dramatic structural changes upon 
binding to EphA4. The EphA4-bound ephrinB2 structure has RMS deviations of 1.06 
Å from the equivalent Cα positions of ephrinB2 in the free state (1IKO), 0.91 Å from 
the Cα positions of ephrinB2 bound to EphB2 (1KGY), 0.80 Å from the Cα positions 
of ephrinB2 bound to EphB4 (2HLE), and 0.89Å and 0.80 Å from the Cα positions of 
ephrinB2 bound to the G attachment glycoproteins of the Nipah (2VSK) and Hendra 
(2VSM) viruses respectively (Figure3.13c). Relatively large conformational changes 
among different ephrin-B2 structures are observed only in the F-G and G-H loops. 
Interestingly, it appears that the G-H loop of ephrinB2 has somewhat different 
conformations when bound to an Eph receptor versus the G attachment glycoproteins 



















Figure 3.13. Crystal structure of the EphA4-ephrin-B2 complex. (a). Overall structure 
of the EphA4-ephrin-B2 complex. (b). Superimposition of the EphA4 structures in 
complex with ephrin-B2 (blue); free EphA4 structures A (green) and B (red) we 
previously determined. (c) Superimposition of ephrin-B2 structures in complex with 
EphA4 (brown); with EphB2 (brown, 1KGY); with EphB4 (purplish blue 2HLE); 
with Hendra viral attachment protein (cyan, 2VSK); with Nipha viral attachment 
protein (red, 2VSM) and free ephrin-B2 (green, 1IKO). 
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3.3.2   Binding interface of the EphA4-ephrin-B2 complex 
The dissociation constant (Kd) for EphA4-ephrinB2 binding measured by 
isothermal calorimetry is 203 nM (Figure 3.14 and Table 3.6). This binding affinity is 
much weaker than those between EphB2 and ephrinB2 (22 nM) and between EphB4 













Figure3.14. ITC characterization of WT-EphA4 and mutated EphA4 binding with 
ephrinB2 and compound1 and 2. (a). The ITC titration profiles of the binding reaction 
of the EphA4 ligand-binding domain with the ephrinB2 ectodomain and integrated 
values for reaction heats with subtraction of the corresponding blank results 
normalized by the amount of ligand injected versus molar ratio of EphA4/ephrinB2 
(b). (c). The ITC titration profiles of the binding reaction of the mutated EphA4 
ligand-binding domain with the ephrinB2 ectodomain and integrated values for 
reaction heats with subtraction of the corresponding blank results normalized by the 
amount of ligand injected versus molar ratio of EphA4 mutant/ephrinB2 (d). (e). The 
ITC titration profiles of the binding reaction of the mutated EphA4 ligand-binding 
domain with the compound 1 and integrated values for reaction heats with subtraction 
of the corresponding blank results normalized by the amount of ligand injected versus 
molar ratio of C1/EphA4 mutant (f). (g). The ITC titration profiles of the binding 
reaction of the mutated EphA4 ligand-binding domain with the compound 2 and 
integrated values for reaction heats with subtraction of the corresponding blank results 
normalized by the amount of ligand injected versus molar ratio of C2/EphA4 mutant 
(h). The detailed conditions and setting of the ITC experiments are presented in 











































To understand the structural basis of the differences in ephrinB2 binding affinity 
for EphA4 versus EphB receptors, we performed a detailed analysis of the binding 
interface between EphA4 and ephrinB2. 
The EphA4-ephrinB2 interface centers around the ephrinB2 G-H loop, which is 
inserted into a hydrophobic channel of the EphA4 receptor, as observed previously for 
other Eph-ephrin complexes (Figure 3.15a). The EphA4 D, E and J β-strands serve as 
the sides of the channel, and the G and M strands form the back of the channel, which 
is further capped by the EphA4 G-H loop. Interactions between the ephrinB2 G-H 
loop and the EphA4 channel appear dominated by Van der Waals contacts. In 
particular, the side chains of residues Leu124 and Trp125 at the tip of the ephrinB2 G-
H loop establish extensive hydrophobic interactions with the EphA4 hydrophobic side 
chains of Ile31 in the D strand, Val167 in the M strand and Phe126, Val129, Ile135 
and Leu138 in J-K loop. Furthermore, the aromatic ring of ephrinB2 Phe120 
establishes hydrophobic interactions with the side chains of EphA4 Leu83 and Pro84. 
In addition, Pro122 of ephrinB2 is in direct contact with Ala165 in the M strand of 
EphA4 as well as the EphA4 disulfide bridge between Cys45 and Cys163. Besides the 
hydrophobic contacts, there are two polar interactions between EphA4 and ephrinB2 
in the channel. The first is a salt bridge between ephrinB2 Glu128 and EphA4 Arg78, 
a residue that is conserved in all Eph receptors except EphB4 (in which the equivalent 
residue is Leu) (6). The second is a side-chain hydrogen bond between ephrinB2 
Gln118 and EphA4 Gln43 (Figure 3.15b). 
 
















Figure 3.15. Anatomy of the EphA4-ephrin-B2 binding interface. (a). Hydrophobic 
interactions between EphA4 and ephrin-B2. The ephrin-B2 hydrophobic residues are 
labeled. (b). Polar interactions between EphA4 and ephrin-B2. The residues involved 
in polar interactions within the binding channel are labeled: a side chain hydrogen 
bond between EphA4 Gln43 and ephrin-B2 Gln118; and a side chain salt bridge 
between EphA4 Arg78 and ephrin-B2 Glu128.  
 
Interestingly, in the previously described EphB2-ephrinB2 complex (Himanen et al, 
2001), Tyr57 in the D-strand of mouse EphB2 (corresponding to Tyr50 in human 
sequence, Figure 3.16) engages in an aromatic-hydrophobic interactions with Leu160 
in the J-K loop of EphB2 and Leu127 in the G-H loop of ephrinB2 (Figure 3.18a). 
These interactions lead to the formation of a hydrophobic patch, which is absent in the 
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EphA4-ephrinB2 complex (Figure 3.18a) because the EphA4 residue structurally 
equivalent to EphB2 Tyr57 is a Met (Figure 3.18). The absence of this hydrophobic 
patch in the EphA4-ephrinB2 complex appears to be responsible for the 10.3 Å 
movement of the EphA4 J-K loop away from ephrinB2 compared to the equivalent 
region in the EphB2-ephrinB2 complex. As a consequence, the J-K loop of EphA4 
interacts more loosely with the ephrinB2 G-H loop than the J-K loop of EphB2. This 
may at least in part account for the relatively low binding affinity between EphA4 and 
ephrinB2. In the EphB4 receptor, the residue corresponding to EphB2 Tyr57 is also a 
Met, and the hydrophobic patch observed in the EphB2-ephrinB2 complex is also 
absent. However, the EphB4 J-K loop forms a short two-stranded β-sheet with a Pro 
at the β-turn position, which establishes additional contacts with the ephrin-B2 G-H 
loop, such as those between EphB4 Pro151 and ephrinB2 Phe120. These additional 
contacts, together with the other contacts between ephrinB2 Phe120/Pro122 and 
EphB4 Leu95 (which corresponds to an Arg in all other Eph receptors), may partly 
compensate for the absence of the hydrophobic patch and still yield a high binding 
affinity for the EphB4-ephrinB2 interaction. There is also a second contact region in 
the EphA4-ephrinB2 interface, structurally separate from the channel and involving 
extensive surface polar contacts mediated by a network of hydrogen bonds and salt 
bridges between the upper surface of EphA4 (A-C loop and D and E strands) and 
ephrinB2 C, G and F strands (Figure 3.18b). These polar interactions include 
hydrogen bonds between Gln109L and Gln12R (where L indicates the ligand and R 
the receptor), Thr114L and Ser30R/Arg40R, Lys60L and Glu28R, Gln118L and 
Gln43R, and Thr99L and Asn36R as well as salt bridges between Lys112L and 
Glu14R, Lys116L and Glu27R, and Glu128L and Arg78R. Within this surface contact 
region, Gln12 and Glu14 of EphA4 together with Gln109 and Lys112 of ephrinB2 
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would be predicted to play a particularly critical role (Figure 3.18b). More specifically, 
Gln12 in the A-C loop of EphA4 forms a side-chain hydrogen bond with Gln109 in 
the F-G loop of ephrinB2, and Glu14 in the A-C loop of EphA4 forms a side-chain 
salt bridge with Lys112 in the G β-strand of ephrinB2. Among the Eph-ephrin 
complex structures reported so far, similar contacts were observed in the EphB2-
ephrinB2 and EphB4-ephrinB2 complexes, but not in the EphA2-ephrinA1 complex 



































Figure 3.17. Structures of the Eph-ephrin complexes. (a) The EphB2-ephrin-B2 
(1KGY) complex structure with the structurally equivalent contact region for that 
observed in the EphA4-ephrin-B2 as shown in Figure 4b. (b) The EphB4-ephrin-B2 
(2HLE) complex structure with the structurally equivalent contact region. (c) The 
EphB2-ephrin-A5 (1SHW) complex structure without the structurally equivalent 
contact region. (d) The EphA2-ephrin-A1 (3CZU) complex structure without the 































Figure 3.18. Unique features for the EphA4-ephrin-B2 complex. (a). Comparison of 
the conformations of the Eph receptor J-K loops in the EphA4-ephrin-B2 and EphB2-
ephrin-B2 (1KGY) complexes. (b). A contact region identified in the EphA4-ephrin-






3.3.3   Ligand-binding properties of the EphA4 Gln12/Glu14 mutant 
To investigate the contribution of the surface contact region to the binding affinity 
and promiscuity between EphA4 and ephrinB2, we replaced with alanines the 
residues of EphA4 and ephrin-B2 involved in the interface and expressed the mutant 
proteins in E. coli. Mutation of Gln12 and Glu14 in the A-C loop of EphA4 did not 
result in significant overall conformational changes, as judged by circular dichroism 
and NMR characterization (Figures 3.19b and 3.19c). Nevertheless, the affinity of the 
EphA4 mutant for ephrinB2 is ~ 10-fold lower than that of wild-type EphA4 (Figure 
3.14 and Table 3.6). Interestingly, while the entropy change (ΔS) associated with the 
binding of ephrinB2 to mutant EphA4 remains mostly unchanged compared to wild-
type EphA4, the enthalpy change (ΔH) is significantly lower. This implies that the 
hydrophobic interactions between the ephrin-B2 G-H loop and the EphA4 channel are 
very similar for both wild-type and mutant EphA4. However, mutation of EphA4 
Gln12 and Glu14 to Ala disrupts the polar surface interactions with ephrinB2, thus 
leading to a significant difference in ΔH. Two small molecule antagonists designated 
compound 1 and compound 2 were previously found to target the ephrins binding 
channel of EphA4, thus antagonizing the binding of several ephrins. We found that 
the Kd and ΔS values for the binding of the two compounds to mutant and wild-type 
EphA4 are very similar (Figure 3.14 and Table 3.6). Furthermore, the binding of the 
two compounds perturbs the same residues of wild-type and mutant EphA4 in NMR 
HSQC titrations (spectra not shown). These results indicate that mutation of Gln12 
and Glu14 to Ala does not detectably affect the EphA4 ligand-binding channel, which 




























Figure 3.19. CD and NMR characterization of EphA4 and ephrin-B2 mutants. (a). The 
far-UV CD curves of the wild-type ephrin-B2 (blue) and its mutant (red). (b). The far-
UV CD curves of the wild-type EphA4 (blue) and its mutant (red). (c). Two 





To investigate the contribution of the surface contact region to the binding affinity 
of EphA4 for different ephrins, we performed ELISA binding assays using the EphA4 
ligand-binding domain fused to alkaline phosphatase (AP) and ephrin Fc fusion 
proteins generated in eukaryotic cells. The Kd values for the binding of mutated 
EphA4 to ephrinA1, ephrinA4 and ephrinA5 are very similar to those of wild type 
EphA4, suggesting that Gln12 and Glu14 do not play an important role in ephrinA 
binding. In contrast, mutant EphA4 shows a ~10-fold lower affinity for ephrinB2 and 
ephrinB3 compared to wild-type EphA4, demonstrating a critical role of the two 
residues (Figure 3.20). It should be noted that the apparent Kd values measured in the 
ELISA assays are much lower than those obtained by isothermal titration calorimetry. 
This is due to the dimeric nature of alkaline phosphatase fusion proteins, which 
therefore have increased avidity. Furthermore, the concentration of fusion proteins 
calculated based on alkaline phosphatase activity may be underestimated. 
Nevertheless, these results clearly indicate that EphA4 Gln12 and Glu14 do not play 
an important role in the binding of ephrinA ligands, whereas they are critical for the 







Figure 3.20. Binding properties of EphA4 and its mutant to different ephrin ligands.              
(a) Binding curves and Kd values of EphA4 (black) and EphA4 mutant (grey) to 
ephrin-A1. (b) Binding curves and Kd values of EphA4 (black) and EphA4 mutant 
(grey) to ephrin-A4. (c) Binding curves and Kd values of EphA4 (black) and EphA4 
mutant (grey) to ephrin-A5. (d) Binding curves and Kd values of EphA4 (black) and 
EphA4 mutant (grey) to ephrin-B2.   (e) Binding curves and Kd values of EphA4 
(black) and EphA4 mutant (grey) to ephrin-B3. (Data from collaborator’s group, R. 
Noberini, JBC, 2009) 
 
3.3.4   Receptor-binding properties of the ephrin-B2Gln109/Glu112 mutant 
Structural characterization by circular dichroism suggests that ephrinB2 appears to 
become more helical when Gln109 and Lys112 are mutated to Ala (Figure 3.19a). 
This is reasonable given that Lys112 is located on the G β-strand and Ala is known to 
be a helix-inducing residue. Despite these structural changes, the affinity of mutant 
ephrinB2 AP for EphB receptors in ELISA assays was reduced by only 2-4 fold 
compared to wild-type ephrinB2 AP (Figure 3.21). This suggests that Gln109 and 
Lys112 play a relatively minor role in EphB receptor binding and that most of the 
binding affinity depends on the interaction of the ephrinB2 G-H loop with the EphB 
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channel. In contrast, the affinity of the mutant ephrinB2 for EphA4 was much more 
compromised and the binding was barely detectable (Figure 3.21), consistent with the 
effect of the complementary mutations in EphA4 and a key importance of the surface 









Figure 3.21. Binding properties of wide type and mutated ephrin ligands with Eph 
receptors. (a) Binding curves and Kd values of wide type (black) and mutated (grey) 
ephrinB2 with EphA4. (b) Binding curves and Kd values of wide type (black) and 
mutated (grey) ephrinB2 with EphB1. (c) Binding curves and Kd values of wide type 
(black) and mutated (grey) ephrinB2 with EphB2. (d) Binding curves and Kd values 
of wide type (black) and mutated (grey) ephrinB2 with EphB3. (e) Binding curves and 
Kd values of wide type (black) and mutated (grey) ephrinB2 with EphB4. (f) Binding 
curves and Kd values of wide type (black) and mutated (grey) ephrinB2 with EphB6. 







3.3.5  NMR visualization of structural perturbations occurring in EphA4 upon 
ephrinB2 binding 
     We also used NMR spectroscopy to gain further insights into the interaction of 
wild-type and mutated EphA4 with ephrinB2 in solution. In NMR HSQC titrations, 
the binding between wild-type EphA4 and ephrinB2 was saturated at a molar ratio of 
1:1.5 (EphA4/ephrin-B2), consistent with the relatively strong binding affinity 
between the two proteins. Surprisingly, only a small portion of EphA4 HSQC peaks 
shifted while the majority disappeared upon ephrinB2 binding (Figure 3.22a).  
This observation implies that the binding to ephrinB2 would provoke significant 
conformational exchanges on the μs-ms time scale over the whole EphA4 ligand-
binding domain as we previously observed on the Nck2 SH2 domain upon binding to 
phosphorylated ephrin-B2 cytoplasmic domains. Furthermore, mapping the perturbed 
EphA4 residues onto the EphA4-ephrinB2 complex structure shows that they are 



























Figure 3.22. NMR HSQC mapping of the binding interfaces. (a). Superimposition of 
the NMR HSQC spectra of the wild-type EphA4 in the absence (blue) and presence 
(red) of ephrin-B2 at a molar ratio of 1:1.5 (EphA4/ephrin-B2). (b). Superimposition 
of the NMR HSQC spectra of the mutated EphA4 in the absence (blue) and presence 
(red) of ephrin-B2 at a molar ratio of 1:3 (EphA4 mutant/ephrin-B2). The assignments 




    On the other hand, the binding between mutant EphA4 and ephrinB2 is saturated at 
a molar ratio of 1:3 (mutant EphA4/ephrinB2), consistent with the weaker binding 
between the two proteins. Strikingly, only a small portion of the mutant EphA4 
residues were perturbed by the binding of ephrinB2 (Figure 3.22b). Furthermore, all 
of the perturbed residues center around the binding interface with the ephrinB2 G-H 
loop (Figures 3.23b). In contrast to wild-type EphA4, residues in the A-C loop of 
mutant EphA4 were not perturbed even at a molar ratio of 1:8. Almost all the 
perturbed residues in the mutant EphA4 have direct contacts with ephrinB2 in the 
crystal structure (Figures 3.15 and 3.23), including Glu27, Val29, Ser30 and Ile31 in 
the D β-strand; Arg40 and Gln43 in the E β-strand; Ala165 in the M β-strand; Glu34 
in the D-E loop; Phe126, Thr127, Gln128, Gly132, Asp133, Leu138 and Asn 139 in 
the J-K loop; and Arg78, Cys80, Leu83, Cys90 and Lys91 in the G-H loop. 
Interestingly, we also observed a significant perturbation of Cys163, which forms a 
disulfide bond with Cys45. This disulfide bond is conserved in different Eph receptors 

























Figure 3.23. Binding interfaces mapped out by NMR.  (a). The binding interface of 
the wild-type EphA4 with ephrin-B2 mapped out by NMR HSQC titrations. (b). The 
binding interface of the mutated EphA4 with ephrin-B2. The shifted residues are 







3.3.6   Discussion 
The binding promiscuity between Eph receptors and ephrin ligands appears to 
be a key strategy enabling Eph-ephrin signaling networks to control a wide array of 
biological functions. Understanding the structural principles governing promiscuity 
versus selectivity of Eph receptor-ephrin binding is therefore an important step to 
elucidate the mechanisms underlying the biological functions of the Eph system and is 
also critical for the design of antagonists to target Eph-ephrin interactions. EphA4 is 
the only Eph receptor that can bind with substantial affinity all ephrin-A and ephrin-B 
ligands (Pasquale EB, 2004). Here we report the structure of the EphA4-ephrin-B2 
complex, which represents the first structure of a complex between an EphA receptor 
and an ephrin-B ligand.  
The overall architecture of the EphA4-ephrin-B2 complex is very similar to 
those previously determined for other Eph-ephrin complexes. The high affinity 
interface of the complex can be divided into two relatively-independent regions. One 
mostly involves the hydrophobic interactions between the EphA4 ligand-binding 
channel and the ephrin-B2 G-H loop. The other, which was observed in the EphB-
ephrin-B complexes, but was greatly reduced in the EphA2-ephrin-A1 complex and 
absent in the EphB2-ephrin-A5 complex, involves polar interactions between surface 
residues: Gln12 and Glu14 in EphA4 and Gln109 and Lys112 in ephrin-B2. In the 
EphA4-ephrin-B2 complex, we did not obtain evidence for a distinct lower affinity 
binding interface that may mediate tetramerization of two EphA4-ephrin-B2 
heterodimers similar to what has been described for the EphB2-ephrin-A5 complex. 




Several notable structural variations are observed in critical regions of the high 
affinity EphA4-ephrin-B2 dimerization interface upon complex formation. Several 
EphA4 regions – including the D and E β-strands as well as the A-C, D-E, G-H and J-
K loops – undergo significant conformational rearrangements to accommodate the 
ephrin-B2 ligand. In particular, the short β-strand observed in one of the conformers 
of the free EphA4 is completely rearranged into a loop suitable for interacting with 
the ephrin-B2 G-H loop. This observation is in agreement with previous studies with 
EphB receptors, which show that significant structural rearrangements occur in these 
regions to enable the formation of Eph-ephrin complexes . In contrast, only minor 
structural changes have been observed upon formation of the EphA2-ephrin-A1 
complex. 
The EphA4-ephrin-B2 structure also explains the relatively weak affinity of 
the interclass EphA4-ephrin-B2 binding (Kd of 203 nM) compared with intraclass 
interactions, such as those of EphB2 with ephrin-B2 (Kd of 22 nM) and EphB4 with 
ephrin-B2 (Kd of 40 nM). Because of sequence variations, a hydrophobic patch 
present in the EphB2-ephrin-B2 complex is absent in the EphA4-ephrin-B2 complex. 
As a consequence, half of the EphA4 J-K loop remains open and does not make any 
contacts with the ephrin-B2 G-H loop (Figure 3.19a). Given that the structurally-
equivalent EphB2 loop region in the complex with ephrin-A5 is more open and the 
binding affinity of EphB2 for ephrin-A5 is even lower (Kd of 320 nM), this feature 
likely accounts at least in part for the low binding affinity between EphA4 and ephrin-
B2. However, comparing Kd values for wild-type and mutated proteins shows that the 
surface contacts formed between EphA4 residues Gln12 and Glu14 and ephrin-B2 
residues Gln109 and Lys112 increase by about 10 folds the binding affinity and thus 
play a critical role in interclass EphA4-ephrin-B2 binding.  
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Mutation of the two EphA4 residues involved in the interface yields an EphA4 
mutant that does not undergo any global structural changes or modifications in the 
ephrin-binding channel. This is evident from the unchanged binding affinity of the 
EphA4 mutant for two small molecule antagonists that bind within the channel. 
Interestingly, the surface contact region of EphA4 does not appear to be necessary for 
the intraclass binding with ephrin-A ligands, which probably involves a more intimate 
fit between the EphA4 ligand-binding channel and the ephrin-A G-H loop. This is the 
case for the EphA2-ephrin-A1 complex, where the polar surface contact region is 
extremely reduced. Similarly, this region is likely not present or minimal in EphA4-
ephrin-A complexes. On the other hand, Gln109 and Lys112 of ephrin-B2 have been 
shown to also interact with residues on the surface of EphB receptors, which could 
explain the 2-3 fold decrease in the affinity of mutant ephrin-B2 for EphB receptors. 
However, we cannot exclude that the decrease in binding may be due to the changes 
in the overall conformation of the mutant ephrin observed by CD spectroscopy. 
Nevertheless, the much more pronounced impairment in the binding of mutant ephrin-
B2 to EphA4 than to EphB receptors suggests that the surface contact region is much 
more critical for the interclass EphA4-ephrin-B2 binding than the intraclass EphB-
ephrin-B2 binding. Interestingly, the residue corresponding to ephrin-B2 Gln109 is a 
Leu in ephrin-B3, and therefore cannot be involved in the hydrogen bond with EphA4 
Gln12 that instead is present in the EphA4-ephrin-B2 complex. However, the binding 
affinity of EphA4 mutant for ephrin-B2 or ephrin-B3 is equally reduced compared to 
wild-type EphA4, suggesting that the salt bridge between ephrin-B2 Lys 112 and 




 The availability of both wild-type and mutated EphA4 receptors has given us 
the unique opportunity to use NMR spectroscopy to gain new insight into the 
dynamics of the EphA4-ephrin-B2 complex in solution, which could not be achieved 
from analysis of the more static crystallized complex. Interestingly, the NMR data 
show that many of the EphA4 residues perturbed upon ephrin-B2 binding are located 
outside the high affinity EphA4-ephrin-B2 binding interface. For example, many 
residues in the EphA4 L and H strands are far away from the binding interface but 
they are significantly perturbed. Interestingly, in the crystal structures these residues 
do not appear to undergo any significant conformational changes upon ephrin-B2 
binding (Figure 3.14b). The observed perturbations by NMR may be explained by 
changes in the dynamics of various EphA4 regions upon ephrin-B2 binding. In 
contrast, once the interactions mediated by EphA4 Gln12 and Glu14 are removed, the 
residues perturbed by the binding of ephrin-B2 are only limited to the EphA4 
interface in direct contact with ephrin-B2. Thus, contacts mediated by Gln12 and/or 
Glu14 have far-reaching effects over the entire EphA4 ligand-binding domain. It is 
tempting to speculate that these dynamic perturbations may reflect changes in EphA4 
that affect its biological function upon ephrin binding. 
The new EphA4-ephrin-B2 complex structure that we have characterized, 
together with those previously determined for other Eph receptor-ephrin pairs, 
highlights a surprising diversity in the use of the two regions of the high affinity 
interface to accomplish intraclass or interclass Eph receptor-ephrin binding. For 
example, it appears that intraclass binding is mediated almost exclusively (A class) or 
predominantly (B class) by the hydrophobic Eph channel/ephrin G-H loop region of 
the interface. Accordingly, the fit of the ephrin G-H loop into the Eph channel is more 
intimate for the A than the B class. EphB2-ephrin-A5 interclass binding relies only on 
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the channel region of the interface, although the loose interclass fit of the EphB 
channel and the ephrin-A G-H loop results in the lowest binding affinity among the 
complexes structurally characterized so far. Interestingly, we found that EphA4-
ephrin-B2 interclass binding uses a unique strategy, where very weak binding through 
the Eph channel/ephrin G-H loop is supplemented by interactions in the polar surface 
contact region of the interface. In this manner, EphA4 achieves the highest 
promiscuity among the Eph receptors.  
As a consequence of this variability in Eph receptor-ephrin interfaces, the 
design of antagonists to target Eph-ephrin interactions may be more challenging than 
previously thought and diverse strategies may be needed depending on the Eph 
receptor and the ephrin involved. Consistent with this notion, we previously found 
that two small molecule antagonists that target the ephrin-binding channel of EphA4 
inhibit the binding of some ephrins but not others. For example, we did not detect 
inhibition of ephrin-B2 and ephrin-A4 binding to EphA4, at concentrations that 
completely inhibited the binding of other ephrins. The structural information we 
obtained and the effects of the EphA4 and ephrin-B2 mutations also suggest that it is 
possible to selectively inhibit EphA4 binding to ephrin-B but not ephrin-A ligands by 
disrupting the polar surface region of the high affinity interface, while the binding of 
ephrin-A ligands to EphA4 may be selectively inhibited by disrupting appropriate 
contacts in the channel region. Such strategies may help dissect the biological roles of 
intraclass versus interclass EphA4-ephrin binding and guide more selective 











3.4   Interactions of EphA4 Ligand Binding Domain with 











As mentioned in introduction, the critical roles of EphA4 in various physiological 
and pathological processes validate this receptor as a promising target for the 
development of small molecule drugs to treat human diseases. Until now, by targeting 
Eph-ephrin binding pocket, only two small molecules have been identified by a high 
throughput screening, which are able to antagonize ephrin-induced effects in EphA4-
expressing cells (Noberini R et al, 2008).  It is of significant interest to gain structural 
insight into the binding interactions between the two small molecules and the EphA4 
ligand-binding domain, with the ultimate goal to develop small molecule antagonists 
capable of inhibiting Eph-ephrin binding with high affinity and specificity. In our 
study, we characterized its binding to two antagonistic small molecules namely 4- and 
5-(2,5 dimethyl-pyrrol-1-yl)-2-hydroxy-benzoic acid by use of isothermal titration 
calorimetry (ITC), circular dichroism (CD), nuclear magnetic resonance (NMR) 
spectroscopy and computational docking. 
 
3.4.1   Binding interactions characterized by ITC and CD 
Recently, two isomeric 2,5-dimethylpyrrolyl benzoic acid derivatives have been 
identified by a high throughput screening to antagonize ephrin-induced effects in 
EphA4-expressing cells (Noberini R et al, 2008).  To assess whether the two small 
molecules directly interact with the EphA4 ligand-binding domain, we utilized ITC to 
measure their thermodynamic binding parameters. Strikingly, by using a high EphA4 
concentration (70 µM), we succeeded in obtaining these parameters, which are 
presented in Table 3.7, thus clearly confirming that the two small molecules do 
interact with the ligand-binding domain of EphA4.  Interestingly, the two compounds 
have similar binding affinities for the EphA4 ligand binding domain, with Kd values 
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of 20.4 µM for compound 1 and 26.4 µM for compound 2, but their binding causes 
different enthalpy changes (ΔH values of -1,001 for compound 1 and -237 cal for 
compound 2).     
 
Table 3.7: Thermodynamic parameters for the binding interactions between EphA4 
































































































Figure 3.24. The ITC titration profiles of the binding reaction of the EphA4 ligand-
binding domain with compound 1: (a); and with compound 2: (c). Integrated values 
for reaction heats with subtraction of the corresponding blank results normalized by 
the amount of ligand injected versus molar ratio of compound 1/EphA4 (b) and of 
compound 2/EphA4(d). 
 
Far-UV CD spectroscopy was also used to monitor the overall structural changes in 
the EphA4 ligand-binding domain upon binding of the two molecules.  As seen in 
Figure 3.25a, no significant difference is detected between the far-UV CD spectra of 
EphA4 in the absence and in the presence of the two molecules at a molar ratio of 1:6 
(EphA4:compound).  This result implies that no significant changes in secondary 
structure occurred in the EphA4 ligand binding domain upon binding, which is 





















Figure 3.25. Characterization of the interactions with two small molecule antagonists. 
(a) Far-UV CD spectra of the EphA4 ligand-binding domain in the absence (black) 
and in the presence of compound 1 (blue) or compound 2 (red) at a molar ratio of 1:6 
(EphA4:compound). (b) The 1H-15N NMR HSQC spectra of the EphA4 ligand-
binding domain in the absence (blue) and in the presence of compound 1 (red) at a 
molar ratio of 1:6 (EphA4:compound). (c) Residue-specific chemical shift differences 
(CSD) of the EphA4 ligand-binding domain in the presence of compound 1 (red) at a 
molar ratio of 1:6 (EphA4:compound). (d) Residue-specific chemical shift differences 
(CSD) of the EphA4 ligand-binding domain in the presence of compound 2 (red) at a 




3.4.2   Binding interactions characterized by NMR  
Because the two small molecules have medium binding affinity for EphA4, it 
is challenging to obtain stable receptor-compound complexes for co-crystallization.  
We therefore decided to probe their binding interactions using NMR spectroscopy, 
which is highly sensitive to weak binding. We prepared 15N/13C double-labeled 
EphA4, collected a series of three-dimensional heteronuclear NMR spectra at a 
protein concentration of 500 µM, and completed the sequential assignments. As 
evident from the very large dispersions in both dimensions (3.7 ppm for 1H and 25 
ppm for 15N) of the HSQC spectrum (Figure 3.25b), the EphA4 ligand-binding 
domain is well-folded in solution. Only one set of HSQC peaks was observed for all 
the EphA4 residues, suggesting that the asymmetric dimer observed in the crystals 
does not exist in solution on the NMR time scale.  
We subsequently used NMR HSQC titrations to detect the EphA4 residues 
that were perturbed by the binding of two compounds. Since the chemical shift value 
of a NMR active atom is sensitive to its chemical environment, chemical shift 
perturbation analysis upon titration of ligands represents a powerful method for 
identifying residues that directly contact the ligands or that are indirectly affected by 
the binding event. Two-dimensional 1H-15N HSQC spectra of 15N-labeled EphA4 
were recorded to monitor the changes of the HSQC cross-peaks of the amide groups 
induced by successive additions of the two compounds.  We observed a gradual shift 
of the EphA4 HSQC peaks, correlating with the increased concentrations of the two 
molecules, which suggests that the free and bound EphA4 molecules undergo a fast 
exchange on the chemical shift timescale.  This allowed assignment of the resonances 
in the complex by following the shifts in the EphA4 cross-peaks upon gradual 
addition of increasing amounts of two compounds. 
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The shift of many HSQC peaks was largely saturated at a molar ratio of 1:6 
(EphA4:compounds).  Therefore, to identify the interaction surfaces, the chemical 
shift differences (CSD) between the free state and the bound state in the presence of a 
6-fold excess of the two compounds were calculated and plotted versus the EphA4 
sequence (Figures 3.25c and 3.25d). The two compounds induced a similar shift 
patterns for the EphA4 residues and most EphA4 residues did not experience large 
chemical-shift perturbations, indicating that the two compounds did not alter the 
overall structure of EphA4, consistent with the far-UV CD results shown in Figure 
3.25a. Interestingly, we observed only 8 resonance peaks with significant CSD 
(deviating more than 2.5 standard deviations from the mean CSD), including residues 
Ile31-Met32 and Ile39 located in the D-E loop, Gln43 in the E β-strand, and Asp123 
and Ile131-Gly132 in the J-K loop.  Since the E β-strand and the D-E and J-K loops 
have been previously demonstrated to be key components of the high-affinity ephrin-
binding channel of the Eph receptors, the NMR titration results thus suggest that the 
two molecules bind to the high-affinity ephrin-binding channel of EphA4.   
Further attempts to identify the intermolecular NOE connectivity between 
EphA4 and the ligand molecules were not successful because the presence of the 
molecules appeared to induce significant intermediate conformational exchanges on 
the NMR timescale over the involved side-chains, which even caused the 
disappearance of their own intermolecular and intraresidue NOEs.  On the other hand, 
with progressive addition of the EphA4 protein, all 1H resonance peaks of the two 
molecules underwent line broadening and gradual shifting in one-dimensional NMR 
spectra. This indicates that the free and bound forms of the two molecules were in fast 
exchange on the chemical shift timescale and also suggests that the entire molecules 
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were either directly or indirectly affected by binding to EphA4, consistent with their 
small size.  
 
3.4.3   Molecular docking 
The absence of intermolecular NOEs between the EphA4 ligand-binding 
domain and the two molecules made it impossible to calculate the structures of their 
complexes with NMR distance constraints.  As an alternative, we used the 
HADDOCK docking strategy to construct models of EphA4 in complex with the two 
molecules. HADDOCK is a recent but well-established docking procedure that makes 
use of NMR chemical shift perturbation data in conjunction with the CNS program to 
drive the molecular docking of protein-protein and protein-small molecule complexes.  
Here we used the x-ray structures solved in our lab to built up the docking model. As 
described in our previous publication (Qin et al, 2008), in crystal, each asymmetric 
unit contains two EphA4 molecules A and B, which show large structural differences 
in the J-K loop.  We have therefore analyzed the NMR Cα, Cβ and Hα chemical shifts 
of the EphA4 ligand-binding domain in solution and found that the four residues 
Phe126-Val129 in the J-K loop show a preference to form a short β-strand, as 
observed in molecule B. However, it appears that in solution the J-K loop might 
undergo an exchange between the two conformations observed in the crystal because 
the chemical shift deviations of the Phe126-Val129 residues are not as large as those 
for the well-formed β-strands in the same EphA4 ligand-binding domain. 
To capture the binding properties of the small molecules with EphA4 
structures, we used both conformations (molecule A and molecule B) to construct the 
complex models by using the HADDOCK docking procedure and obtained models of 
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EphA4 and two compounds. From the structures obtained from the computational 
docking, we selected the three with the lowest energies for further display and 
analysis (Figures 3.26a and 3.26b). As revealed from complex models, the initial 
EphA4 structures only need some local conformational rearrangements to 
accommodate the two small molecules.  As such, the average rms deviations between 
the 3 selected structures and the initial structure are relatively small: only ~2.0 (all 
protein atoms) and 1.1 Å (protein backbone atoms) for EphA4(A)-compound 1; ~2.1 
(all protein atoms) and 1.2 Å (protein backbone atoms) for EphA4(A)-compound 2; 
~1.9 (all protein atoms) and 1.0 Å (protein backbone atoms) for EphA4 (B)-
compound 1; and ~1.8 (all protein atoms) and 1.0 Å (protein backbone atoms) for 
EphA4 (B)-compound 2.  If not considering the D-E and J-K loops, the rms deviation 
values reduce to ~0.8 (all protein atoms) and 0.3 Å (protein backbone atoms) for 
EphA4(A)-compound 1; ~0.8 (all protein atoms) and 0.3 Å (protein backbone atoms) 
for EphA4(A)-compound 2; ~0.9 (all protein atoms) and 0.4 Å (protein backbone 
atoms) for EphA4 (B)-compound 1; and ~0.8 (all protein atoms) and 0.3 Å (protein 
backbone atoms) for EphA4 (B)-compound 2. 
As seen in Figures 3.26 and Figure 3.27,  The two small molecules interact 
mainly with residues Ile31-Met32 in the D-E loop, Gln43 in the D-E β-strand and 
Ile131-Gly132 in the J-K loops, all of which have significant chemical shift 
differences (CSDs) in the NMR HSQC titration (Figures 3.25c and 3.25d).  In contrast, 
despite being set as “active residues” in the docking, residues Ile39 on the D-E loop 
and Asp123 on the J-K loop do not have direct contact with two small molecules in 
these models, implying that the chemical shift perturbations observed for these two 
residues are the secondary effect of binding-induced structural rearrangements of the 



















Figure 3.26. Models of EphA4 (chainA) in complex with small molecule antagonists. 
(a) Stereo view of the superinposition of the unbound EphA4 (green) with its 3 
selected docking models (brown) in complex with compound 1.  (b)  Stereo view of 
the superinposition of the unbound EphA4 (green) with its 3 selected docking models 
(brown) in complex with compound 2.  Both sticks and dots are used to highlight 
residues Ile31-Met32 in the D-E loop, Gln43 in the E β-strand and Ile131-Gly132 in 



















Figure 3.27. Models of EphA4 (chainB) in complex with small molecule antagonists. 
(a) Stereo view of the superinposition of the unbound EphA4 (green) with its 3 
selected docking models (brown) in complex with compound 1.  (b)  Stereo view of 
the superinposition of the unbound EphA4 (green) with its 3 selected docking models 
(brown) in complex with compound 2.  Both sticks and dots are used to highlight 
residues Ile31-Met32 in the D-E loop, Gln43 in the E β-strand and Ile131-Gly132 in 
the J-K loop. 
119 
 
As shown in Figure 3.28, a close examination of all the model structures 
reveals that the pyrrole and benzene rings of the two small molecules stack onto the 
hydrophobic surface formed by residues Ile31 and Met32 in the D-E loop. Moreover, 
the pyrrole ring is sandwiched by the hydrophobic side chains of Ile31-Met32 in the 
D-E loop and those of Ile131 in the J-K loop.  On the other hand, one of the methyl 
groups on the pyrrole ring inserts into the hydrophobic patch between the Ile31 and 
Met32 side chains and the other methyl group is in close contact with the Ile131 side 
chain.  These interactions emphasize the importance of the two methyl groups on the 
pyrrole ring, which is completely consistent with the structure-activity relationship 
analysis of a series of small molecules with the 2,5-dimethylpyrrolyl benzene scaffold 
(Noberini R et al, 2008).  
    In all 12 selected models, the carboxylic and hydroxyl groups on the benzene ring 
always orient towards the side chain of the EphA4 residue Gln43.  Detailed analysis 
indicates that in all these models at least one hydrogen bond forms between the 
oxygen atoms of the carboxylic or hydroxyl groups and the side chain amide protons 
of Gln43.  In some structures, even two hydrogen bonds can be identified between 
them.  This observation may explain why removal of either the carboxylic or the 
hydroxyl group causes a dramatic loss in the activity of the modified compounds 
(Noberini R et al, 2008).  Taken together, the docking results imply that both pyrrole 
and benzene rings, and the two methyl groups on the pyrrole ring, as well as the 
carboxylic and hydroxyl groups on the benzene ring are all critical for the binding of 






Figure 3.28. EphA4 binding pocket for the small molecule antagonists. Surface 
representation of the EphA4 binding pocket of the docking model with the lowest 
energy. (a) EphA4 structure A with compound 1; (c) EphA4 structure B with 
compound1; (b) EphA4 structure A with compound 2; (d) EphA4 structure B with 
compound2 The small molecule antagonists are represented by sticks and oxygen 
atoms are colored in red.  Brown is used for residues Ile31-Met32 in the D-E loop, 







3.4.4   Discussion 
    The extensive involvement of the Eph receptor-ephrin interaction in various 
pathologies suggests that the main interface between the two proteins may serve as a 
promising new target for drug development. Previous studies reveal that the Eph 
receptor-ephrin interaction is mediated by two binding sites in the ligand-binding 
domain of the Eph receptor. One is a high affinity binding site, which includes a 
hydrophobic channel that is mainly constituted by the convex sheet of four β-strands 
and the D-E and J-K loops and that accommodates the protruding G-H loop of the 
ephrin. The other is a separate low affinity binding site (Himanen et al, 2007; 
Himanen et al, 2001; Himanen et al, 2004; Chrencik JE et al, 2007). In particular, the 
high affinity hydrophobic channel of the receptor appears to be highly amendable for 
targeting by small molecule antagonists. However, previously-identified small 
molecules including a natural product from green tea all seem to target the 
intracellular kinase domain of the Eph receptors. Only now two small molecules with 
a 2,5-dimethylpyrrolyl benzene scaffold have been successfully identified in a high 
throughput screen. The fact that the two compounds competitively inhibit ephrin 
binding to EphA4 result strongly suggests that the two compounds occupy the ephrin-
binding channel, thus directly competing with ephrins in binding with the EphA4 
receptor. Therefore, it was of significant interest to define the structural mechanism 
by which the two compounds interact with the EphA4 receptor.  
    To achieve this, we solved the EphA4 ligand binding domain structure in the free 
state by crystallography. This represents the first structure of an Eph receptor of the A 
class. In the crystal, each asymmetric unit contains two EphA4 molecules with a 
novel intermolecular packing interface. On the other hand, the EphA4 ligand-binding 
domain was found to be monomeric in solution by NMR spectroscopy. Interestingly, 
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in the crystal the two EphA4 molecules in the same unit show some large structural 
differences in the J-K loop due to their differential packing interactions with other 
EphA4 molecules in the neighboring asymmetric units.  
    We have used isothermal titration calorimetry, circular dichroism, NMR and 
computational docking to characterize the possible binding interactions of the EphA4 
ligand-binding domain with the two small molecules that inhibit the binding of 
peptide and ephrin ligands. The isothermal titration calorimetry results show that both 
small molecules bind to the EphA4 ligand-binding domain with similar Kd values in 
the micromolar range. On the other hand, consistent with the modest binding affinity 
of the compounds, the circular dichroism results indicate that binding of the two small 
molecules does not induce significant structural changes in the EphA4 ligand-binding 
domain. To identify the EphA4 residues involved in the binding of the two small 
molecules, we have collected a large set of NMR spectra and succeeded in obtaining 
sequential assignments. This allowed us to identify the EphA4 residues that are 
significantly perturbed upon binding of the two small molecules by performing NMR 
HSQC titrations. Interestingly, only a few EphA4 residues showed significant 
perturbations upon binding, which include residues Ile31-Met32 in the D-E loop, 
Gln43 in the E β-strand, and Ile131-Gly132 in the J-K loop, in agreement with the 
small sizes of the two small molecules.  
    We further used the well-established HADDOCK docking procedure to construct 
models of the EphA4 ligand-binding domain in complex with the two small molecules. 
The docking results indicate that both molecules occupy a cavity of the high-affinity 
ephrin binding channel of EphA4 in a similar manner, by interacting mainly with 
EphA4 residues in the E strand and the D-E and J-K loops. The results also reveal that 
all three building blocks of the 2,5-dimethylpyrrolyl benzene scaffold, namely the 
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dimethylpyrrole ring, the benzene ring, and the carboxylic/hydroxyl groups on the 
benzene ring, are crucial for binding to the EphA4 ligand-binding domain. The 
pyrrole and benzene rings appear to play a key role in establishing stacked aromatic-
hydrophobic interactions with Ile31-Met32 on the D-E loop and Ile131 on the J-K 
loop. The two methyl groups on the pyrrole ring further anchor the small molecules in 
between the D-E and J-K loops by using one methyl group to interact with the 
hydrophobic side chains of Ile31-Met32 and the other to interact with the hydrophobic 
side chain of Ile131. Furthermore, the carboxylic and hydroxyl groups on the benzene 
ring are involved in hydrogen bonding to the side-chain amide protons of Gln43 in 
EphA4, thus providing additional contacts with EphA4 as well as dictating the 
orientation of the small molecules in the complexes. Consequently, the docking 
models provide the structural rationale for the results of an extensive study on the 
structure-activity relationship of small molecules with a pyrrolyl benzene scaffold as 
EphA4 ligand-binding antagonists.  
Our results shed light on how such small molecules are capable of selectively 
targeting only EphA4 and the closely related EphA2 receptor. Sequence alignment 
reveals that some of the EphA4 residues that are perturbed by the binding are not 
conserved in other Eph receptors. In particular, residues Ile31-Met32 are only 
presented in EphA4 and EphA2 but not other Eph receptors, which may be at least 
partly responsible for the high binding-selectivity of the two molecules for the EphA4 
and EphA2 receptors. Therefore, in the future, targeting the less-conserved residues 
within the ephrin binding channel may represent a feasible and efficient strategy to 
design small molecules with the ability to specifically target an individual Eph 
receptor of therapeutic interest.  
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    Our results may also explain why the two small molecules bind to EphA4 with a 
relatively weak affinity. First, EphA4 residues Ile31-Met32 and Ile131, which are 
critical for binding, are from the D-E and J-K loops. These loops are relatively 
flexible, as indicated by previous crystal structures and our NMR 15N heteronuclear 
NOE data in the following section. Second, as shown in Figure 3.27a, the two small 
molecules only occupy a portion of the EphA4 ligand-binding channel, which in 
EphB2 and EphB4 is occupied by the tip of the G-H loop of the ephrin ligands 
(Himanen et al, 2007; Himanen et al, 2001; Himanen et al, 2004; Chrencik JE et al, 
2007). In contrast, interactions occurring outside of the high-affinity binding pocket 
of the Eph receptor are totally absent in the case of the small molecules. These 
interactions include those between the ephrin G β-strand and the Eph receptor D and 
E β-strands and A-C loop. Even within the high-affinity binding channel, a large 
portion of the key Eph receptor-ephrin interactions is absent in the EphA4-small 
molecule complexes due to the small size of the dimethylpirrole derivatives. For 
example, NMR titrations did not detect strong interactions between the two small 
molecules and the EphA4 G and M β-strands. Furthermore, as shown in Figure 3.27b, 
the interaction interface between EphA4 and the two compounds is also smaller than 
the interaction interfaces between the EphB2 and EphB4 receptors and their 
respective peptide ligands (Chrencik JE et al, 2006; Chrencik JE et al, 2007). For 
example, the two small molecules do not interact with the EphA4 disulfide bridge 
linking Cys45 and Cys53, whereas this interaction was found to be conserved in all 
the EphB structures in complex with either ephrins or antagonistic peptides (Chrencik 
JE et al, 2007).  
In conclusion, our studies confirm the binding interaction between the EphA4 
ligand-binding domain and two novel small molecule antagonists with a 2,5-
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dimethylpyrrolyl benzene scaffold. Furthermore, we utilized NMR titrations to map 
out the residues involved in the interaction and used this information to construct 
models of the EphA4 ligand-binding domain in complex with the two small molecules. 
These models provide a structural rational for the results of an extensive structure-
activity study on a large set of small molecules with a pyrrolyl benzene scaffold and 
for the high binding selectivity but relatively weak affinity of the compounds. Based 
on our model, we propose that modifications to enhance interactions with the EphA4 
G and M β-strands may represent a promising direction to improve the binding 



















3.5   NMR Structure and Dynamics of EphA4 Ligand 
Binding Domain 










    NMR and crystallography are two major techniques to resolve protein 3D structure 
with high resolution. Crystallography is preferred by researchers because of low cost, 
high accuracy, and relatively less workload on data analysis. However, protein 
dynamic information could be lost due to crystal packing force, but dynamic 
information could be essential in the understanding of protein function. NMR 
spectroscopy can resolve this issue because NMR data is collected from solution 
sample. Therefore, the NMR solution structure of EphA4 ligand binding domain was 
also solved in my thesis. In section 3.2, we have reported 16 EphA4 LBD structures 
from two protein crystals, and structure comparison implies that the loops of EphA4 
LBD are highly flexible. As a complementary aspect for static 3D structure, the 
dynamics of EphA4 ligand binding domain is also studied in this section.  
 
3.5.1   Generation and structural properties of the EphA4 LBD 
Constructs containing EphA4 ectodomain DNA sequence were transformed in E. 
Coli. System (Rosetta gammi, Invitrogen) and EphA4 LBD with correct disulfide 
bonds formation could be produced. Preparation of the protein was illustrated in 
Chapter2.  
Preliminary structural study of EphA4 LBD was characterized by far-UV and near-
UV CD. As seen from far-UV CD spectrum (Figure3.29a), EphA4 LBD has a 
negative peak at 212nm, but a positive peak at 200nm, indicating EphA4 LBD is very 
well behaved and mainly consists of β-strands. Near-UV CD spectrum of EphA4 
LBD changed dramatically upon adding 6M GuHCl to denaturalizing the protein, 
indicating that EphA4 has tight tertiary packing. As seen from Figure3.29b, there is a 
positive peak around 290nm and a negative peak around 270nm under native 
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condition but these two peaks disappeared when protein was denatured by 6M GuHCl. 
To further visualize the structure characters of EphA4, 15N isotope labelled EphA4 
LBD was prepared and 1H-15N HSQC spectrum was collected (Figure3.29c). From 
the spectrum, it could be observed that EphA4 LBD has a well-dispersed HSQC 
spectrum with ~3.75 ppm for 1H dimension and ~25ppm for 15N dimension, 
indicating the protein is suitable for further study by NMR.  However, the peak 
intensities of HSQC spectrun are not uniform, indicating that some regions might 
undergo conformational exchanges on μs-ms time scale. HSQC spectrum also 
revealed that EphA4 ligand binding domain only has one set of HSQC peaks, proving 
that EphA4 LBD is monomeric in solution. The dimerization formed in crystal is 




























Figure 3.29. Structure characterization of EphA4 LBD by CD and NMR spectrum (a) 
Far-UV CD, the spectrum was collected in 10mM phosphate buffer, pH6.3; (b) Near-
UV CD, the spectrum of native EphA4 LBD was collected in 10mM phosphate buffer, 
pH6.3. The spectrum of denatured EphA4 LBD was collected again after 6M GuHCl 
was added in the sample; (c) 1H-15N HSQC spectrum of EphA4 LBD. The spectrum 













































3.5.2   Chemical shift assignment of EphA4 LBD 
High-quality heteronuclear NMR data of the 183-residue EphA4 LBD was 
successfully acquired on an 800 MHz spectrometer with both 15N- and 15N-/13C-
labeled protein samples. Detailed analysis of these data, in particular triple-resonance 
experiments led to almost complete backbone assignments for all 183 residues except 
6Pro, Asn3, Glu4, Val5, Leu17, Ile20, Met50, Glu51, Asp61, Trp62, Ile63, Arg65, 
Gln69, Asp106, Lys107, Glu108, Arg109, Gln115, Phe116, Val131, R136, Ile137, 
Met138, Tyr175 whose HSQC peaks could not be observed under the experimental 
conditions used for structure determination. Chemical shifts for 13C and non-labile 
hydrogens were completed for all sidechain atoms except Ile20, Met50, Glu51, Asp61, 
Trp62, Lys107, Glu108, Arg109, Gln115, Phe116, R136, Ile137 whose 15N-13C 
correlations are unavailable. Chemical shift assignments for all hydrophobic residues 
(8 Ala, 15Val, 13 Ile, 13 Leu, 8 Phe, 4 Trp, 4Met) were almost completed except for 
atoms of Ile20, Met50, Trp62, Ile137; HD, HG atoms of Leu7, Leu8; CD, CG, of 
Leu58, Ile119; HG atoms of Ile63. 
 
3.5.3   Secondary structure characterization by chemical shift 
It is well known that the chemical shift deviation of Cα, Cβ, Hα, and C=O from 
random coil value reflects the secondary structure of protein (Wishart DS et al, 1994). 
After finishing all the chemical shift assignment, the deviation was calculated to 






Figure3.30. EphA4 LBD chemical shift deviation from random coil value provides 
insights in its secondary structure. (a) Hα Chemical shift deviation of EphA4 LBD 
from random coil value; (b) Cα chemical shift deviation of EphA4 LBD from random 
coil value. 
 
    As seen from Figure3.30a, the deviation of Hα is positive in most regions and the 
deviation of Cα is negative in most regions, indicating that these regions are β-strands. 
Interestingly, the positive regions of Figure3.30a are consistent with the negative 
regions of Figure3.30b, implying that the secondary structure tendency derived from 
chemical shift is correct. From Figure3.30, it can be concluded that like other Eph 
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3.5.4   NMR solution structure of EphA4 LBD 
After assigning the chemical shift to all possible atoms, NOE are also assigned by 
HSQC-NOESY and 13C-edited NOESY experiments. The NMR structure of the 
EphA4 LBD was calculated by CYANA program taking restraints from NOE 
distances, TALOS-predicted dihedral angles, and hydrogen bond constraints (Table 
3.8). An ensemble of 10 structures with the lowest target functions were selected from 
the final CYANA calculation and analyzed by procheck. As seen in Figure 3.31, the 
NMR structure of the EphA4 LBD adopts the same Greek key topology constituted 
by an 11 β-stranded barrel as previously revealed for the Eph receptor LBD by 
crystallographic studies. The concave sheet is comprised of strands C, F, L, H, and I, 
and the convex sheet of strands D, E, A, M, G, K, and J, which are connected by 
loops of variable length. As shown in table 3.8 and Figure 3.31, the residues over the 
secondary structure regions are well-defined in all 10 NMR structures, with a 



































Table 3.8: Structural statistics for 10 selected NMR structures of the EphA4 
Experimental constraints for structure calculation 
NOE restraints 
Total      1517 
Intra residue                                          493 
Sequential                                481 
Medium                                    103 
Long-range                                440 
Dihedral angle constraints                        238 
                                                                                    phi  123 
                                                                                    psi  115 
CYANA target function                              1.71 ± 0.32 
Distance violations (>0.20 Å)     5 
Dihedral angle violations (>5º)    0 
Ramachandran statistics (%) 
Most favored:                                   75.6 
Additionally allowed:                            19.5 
Generously allowed:                             3.7 
Disallowed:                                    1.2 
Root mean square deviation (Å)                Secondary structure regions (41-46,56-60, 
71-79,  
                                                                       97-100, 141-147, 157-161, 166-173) 
Backbone atoms        0.86± 0.22 Å 








Figure3.32 shows the NOE distribution of EphA4 LBD. As it is mainly composed 
of β-strands, more than half of NOEs are sequential and long range NOEs. The 
residues that have a lot of long range NOEs are also the residues on β-strands. During 
NOE assignment, a lot of β-sheet characterized NOEs, such as dαN(i,i+1), dNN(i,j), 












































Figure3.33. Sequential NOEs plotted against amino acid sequence 
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Sequential NOEs plot against amino acid sequence is also provided in Figure3.33. 
Strong dαN(i,i+1) and weak dNN(i,i+1) indicate that most regions of EphA4 LBD are 
β-strands. 
 
3.5.5   Comparison of NMR solution structure and crystal structure 
The crystal structures of free EphA4 LBD were also resolved by our group and 
Bowden. et al. independently (Qin et al, 2008; Bowden et al, 2009). From the 
structure resolved in our lab, one asymmetric unit contains two EphA4 LBD 
molecules packed against each other to form asymmetric dimer. In Bowden’s 
structure, there are two EphA4 monomers in one asymmetric unit. The comparison of 
crystal structures shows that except the 12 highly rigid β-strands, the loops are highly 
flexible, especially D-E, J-K, G-H loops, they seem more flexible than other loops 
(Figure 3.34). Like we discussed in section 3.2, Chain A of 3CKH adopts open 


















Figure 3.34. Comparison of EphA4 ligand-binding domain crystal structures. Green: 
Ribbon representation of EphA4 chainB (3CKH); Yellow: Ribbon representation of 
EphA4 chainA (3CKH); Red: Ribbon representation of EphA4 chainB (2WO1); 














Figure 3.35. Comparison between NMR solution structure and X-ray structure.
Green: average NMR structure ensemble of EphA4 LBD; Purple: Chain B (open






In Figure3.35, NMR structure and crystal structure of EphA4 LBD are compared. If 
only superimposed over the β-barrel regions, these structures superimposed very well, 
with a backbone RMS deviation of 1.16 Å, and all atoms RMSD is 1.651 Å. If 
superimposed the whole structure, the backbone RMS deviation is 2.103 Å, and all 
atoms RMSD is 2.946 Å. The dramatic differences come from loop regions, in 
particular those function related loops, such as D-E, J-K, and G-H loops. As we 
discussed in previous section 3.2, these loops are highly flexible and probably this 
character makes EphA4 ligand binding domain can bind to both subclasses of ephrin 
ligands, and makes dramatic conformational change to accommodate G-H loop from 
ephrin logands. The other significant difference from crystal structures is the 
orientation of the second short 310 helix over residue R109 to N114, probably due to 
the lack of long range NOEs between the helical and β-strands nearby. In addition, 
only one set of HSQC peaks were observed for all the EphA4 residues, suggesting 
that the asymmetric dimer observed in the crystals does not exist in solution on the 
NMR time scale. This is consistent with the results of section3.2. Only when enough 
force is provided, J-K loop will transit from closed to open conformation. Otherwise, 
it will adopt closed conformation 
 
3.5.6   Dynamics study of free EphA4 and analysis of relaxation data 
15N NMR relaxation data is shown in Figure 3.36 and Table 3.9, which are very 
enlightening to pinpoint the dynamics of the protein local enviroment on the pico- to 
nano-second timescale as well as dynamic aggregation. In particular, {1H}-15N 
steady-state NOE (hNOE) offers a reliable measure to the backbone flexibility. As 
seen in Figure 3.36a, most residues forming secondary structures have hNOE values 
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larger than 0.75, indicating that they have significantly-limited backbone motion. 
However, in addition to the N- and C-terminal residues with negative hNOE values 
which clearly indicate both termini are extremely-flexible, three additional regions, 
the J-K, G-H, and K-L loops, also have low hNOE values. The first region over the J-
K loop residues D125 to L140 has an average hNOE value of 0.6 while the second 
region over the G-H loop residues L85 to Y91 holds an average hNOE value of 0.58. 
The third region over the K-L loop residues L150-K153 holds an average hNOE value 
of 0.03, indicating this region is also extremely flexible.  
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Figure 3.36. The 15N NMR backbone relaxation data of the EphA4 ligand binding 
domain  in the 10 mM phosphate buffer (pH 6.3) at 25oC collected on a 800-MHz 
Bruker Avance NMR spectrometer. (a). {1H}–15N steady-state NOE intensity bars ; 
(b) 15N T1 (longitudinal) relaxation times, (c). 15N T2 (transverse) relaxation times. 
The secondary structure segments identified from the NMR structure are indicated, 




3.5.7   Modelfree analysis of relaxation data 
NMR relaxation data was analyzed by “Model-Free” formulism with protein 
dynamics software suites (Fushman et al., 1997). Due to the overlap or/and weak 
intensity of many resonance peaks resulting from the relatively-large size and 
presence of many exposed loop residues, 127 out of 176 non-Proline peaks are 
appreciable for the quantitative analysis. The analysis generated squared generalized 
order parameters, S2, which reflect the backbone rigidity (Table 3.10, Figure3.38). 
Similar with relaxation data, the regions with secondary structure have higher S2, 
showing its rigidity at ps-ns time scale; while the loop regions have smaller S2, 
showing its flexibility at ps-ns time scale. 
Model-free analysis also outputs Rex values, which reflects conformational 
exchanges on µs-ms time scale. Strikingly, from figure 3.38b, the whole EphA4 LBD 
seems undergo conformational exchange on µs-ms time scale. Those residues over D-
E, G-H, and J-K loops have larger Rex values, indicating these regions have more 
significant conformational exchange on µs-ms time scale. This property probably is 




















Figure3.38. Backbone order parameter (S2) and Rex determined from 15N relaxation 











3.5.8   Discussion 
Due to its ability to bind with both classes of ephrin ligands, EphA4 receptor is an 
attractive target in understanding the binding promiscuity and specificity between Eph 
receptor and ephrin ligands. Several structures of free and bounded EphA4 LBD have 
been released, but there is no dramatic structural difference between EphA4 and other 
Eph receptors. In the past decades, protein dynamics has attracted attention of 
researchers because it is thought to play important role in protein function and is a 
very important supplementary aspect to static structure. In our previous study, we 
solved NMR structure of ephrinB2 and proved that the function involving loops of 
ephrinB2 ectodomain are highly dynamic in solution, which is different from X-ray 
structure (Ran et al, 2008). Although several X-ray structures of EphA4 have been 
resolved, local dynamic motion could be quenched by packing force during 
crystallization. Therefore, NMR solution structure of EphA4 LBD and its dynamic 
study were carried out in this section, which were helpful in understanding why 
EphA4 can bind both classes of ephrin ligands.  
 The NMR structure of EphA4 LBD shows that EphA4 LBD has rigid β-sheet 
barrel core and flexible loops, which is consistent with X-ray structures. The loops 
forming classical binding channel, D-E, J-K, and G-H loops, are more flexible than 
other loops. This is probably correlated with its ability to make huge rearrangement to 
accommodate G-H loop from ephrin ligands.  
15N relaxation data of EphA4 ligand binding domain was collected and the analysis 
of the relaxation data was carried out by Model-free formulism. Like what we 
observed from structure, the dynamic data shows that D-E, G-H, and J-K loops are 
highly dynamic in solution. Model-free analysis to relaxation data generated squared 
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order parameter S2 and Rex, which reflect the dynamic motion of protein in ps-ns, and 
µs-ms time scale, respectively. The regions with secondary structure has higher S2, 
indicating their rigidity, while loop regions has lower S2, indicating their flexibility.  
 Model-free analysis also outputs Rex values, which reflects conformational 
exchanges on µs-ms time scale. Our results showed that the residues at D-E, G-H, and 
J-K loops have higher Rex, indicating these regions have conformational exchange at 
µs-ms time scale. This result is consistent with the conclusion in section 3.2. There 
are various conformations existed in 16 EphA4 LBD structures. J-K loop would adopt 
open or closed state depending on whether there is G-H loop present. This 
conformational exchange may be important for EphA4 LBD in the transition from 
closed to open states. In addition, the residues over other regions also have smaller 
Rex, indicating these regions also undergo minor conformational exchange on µs-ms 
time scale. Based on our results, the whole molecule of EphA4 LBD seems to 
undergo conformational exchange on µs-ms time scale. Probably this is the reason 
why EphA4 LBD can interact with different types of ephrin ligands. It is interesting 
that EphB2, the only another receptor that bind both subclasses of ephrin ligands, its 
J-K and D-E loops are also undergo dramatic conformational change. It could be 
suggested that the ligand promiscuity of Eph receptors could be directly correlated 







Table3.9: Relaxation data of EphA4 LBD 





V5 0.000914 1.06E-05 0.017014 0.000538 0.62 0.0179 
T6 0.000666 0.000007 0.020526 0.000485 0.8 0.0231 
L7 0.000697 6.2E-06 0.022421 0.000661 0.79 0.0148 
L8 0.00066 6.7E-06 0.020154 0.000615 0.81 0.0177 
D9 0.000741 1.33E-05 0.020685 0.000365 0.85 0.0132 
S10 0.00073 6.5E-06 0.021294 0.000531 0.77 0.0146 
R11 
S12 0.00074 8.8E-06 0.019741 0.000348 0.75 0.0143 
V13 0.000824 8.3E-06 0.01732 0.000443 0.61 0.0194 
Q14 
G15 
E16 0.0008 8.9E-06 0.012466 0.005752 0.38 0.0163 
L17 0.000532 8.6E-06 0.017359 0.005021 0.72 0.0154 
G18 0.00077 6.9E-06 0.018766 0.00492 0.66 0.0134 
W19 0.00077 4.3E-06 0.019842 0.00056 0.71 0.0152 
I20 0.000658 1.12E-05 0.020783 0.000235 0.63 0.0159 
A21 
S22 0.000675 1.06E-05 0.024048 0.000383 0.84 0.0167 
P23 
L24 0.000731 9.5E-06 0.021536 0.000268 0.78 0.029 
E25 0.000695 9.8E-06 0.019138 0.000323 0.64 0.0124 
G26 0.000705 7.8E-06 0.018062 0.000377 0.7 0.0173 
G27 0.000704 7.8E-06 0.020277 0.000345 0.73 0.0161 
W28 0.00067 1.01E-05 0.023553 0.00039 0.8 0.0246 
E29 0.000718 6.1E-06 0.021402 0.000466 0.79 0.0194 
E30 0.000701 7.5E-06 0.021876 0.000403 0.74 0.0209 
V31 0.000701 1.23E-05 0.023402 0.000358 0.75 0.0192 
S32 
I33 0.000693 1.02E-05 0.023108 0.000525 0.74 0.0136 
M34 0.000683 0.00001 0.022362 0.00029 0.68 0.0236 
D35 0.000814 1.05E-05 0.018692 0.000471 0.64 0.0136 
E36 0.000867 4.8E-06 0.017212 0.000517 0.63 0.0254 
K37 
N38 0.000711 9.9E-06 0.019251 0.000409 0.73 0.0153 
T39 0.000684 9.7E-06 0.020521 0.000404 0.77 0.0266 
P40 
I41 0.000721 7.8E-06 0.021399 0.000521 0.67 0.0175 
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R42 0.000642 1.31E-05 0.023322 0.000562 0.74 0.0165 
T43 0.000731 0.000009 0.02236 0.000499 0.77 0.0147 
Y44 0.000746 9.7E-06 0.021585 0.000406 0.88 0.0206 
Q45 0.000723 1.34E-05 0.020789 0.000626 0.87 0.0154 
V46 0.000707 8.5E-06 0.022019 0.000499 0.83 0.0212 
C47 0.000684 1.16E-05 0.022763 0.00049 0.81 0.019 
N48 0.000578 1.03E-05 0.023887 0.00071 0.83 0.0135 




S53 0.000751 7.4E-06 0.0168 0.000404 0.59 0.0131 
Q54 0.00073 6.6E-06 0.01843 0.000339 0.68 0.0143 
N55 0.000669 1.19E-05 0.021544 0.000414 0.81 0.0159 
N56 0.000686 9.6E-06 0.020313 0.000556 0.83 0.0216 
W57 0.000692 1.06E-05 0.023588 0.00016 0.81 0.0318 
L58 0.000565 6.7E-06 0.018656 0.000408 0.78 0.0292 
R59 0.0006 9.9E-06 0.022204 0.000273 0.77 0.018 





R65 0.000634 1.46E-05 0.020987 0.000367 0.74 0.0235 
E66 0.000912 8.3E-06 0.016488 0.000491 0.56 0.0202 
G67 0.000826 0.00001 0.021627 0.000603 0.74 0.0195 
A68 0.00077 1.36E-05 0.023642 0.000574 0.82 0.0151 
Q69 
R70 0.00067 8.3E-06 0.020617 0.000457 0.69 0.019 
V71 0.000729 1.34E-05 0.021869 0.000663 0.83 0.0281 
Y72 0.000712 9.8E-06 0.020811 0.000444 0.85 0.0125 
I73 0.000685 8.7E-06 0.019873 0.000611 0.82 0.0141 
E74 0.000704 9.6E-06 0.021636 0.000313 0.8 0.0133 
I75 0.000707 1.06E-05 0.021842 0.000501 0.88 0.0227 
K76 0.000701 9.9E-06 0.021908 0.000526 0.83 0.0245 
F77 0.00073 9.7E-06 0.022868 0.000711 0.83 0.0211 
T78 0.000754 1.64E-05 0.022914 0.000374 0.87 0.0191 
L79 
R80 0.000729 7.1E-06 0.021037 0.000561 0.72 0.0188 
D81 0.000793 5.4E-06 0.019843 0.000356 0.69 0.0178 
C82 0.000739 1.53E-05 0.024879 0.000501 0.76 0.0159 
N83 0.000787 1.49E-05 0.02247 0.000486 0.69 0.0184 
S84 0.000781 0.000016 0.020244 0.000355 0.65 0.0145 





V88 0.000954 1.13E-05 0.015387 0.000423 0.57 0.0141 
M89 
G90 
T91 0.000956 5.8E-06 0.015012 0.006258 0.56 0.017 
C92 0.000874 8.7E-06 0.01751 0.000522 0.6 0.0164 
K93 0.000757 1.09E-05 0.024213 0.000515 0.74 0.0177 
E94 0.000709 1.47E-05 0.018543 0.000361 0.73 0.0139 
T95 0.000656 8.5E-06 0.02421 0.000354 0.76 0.0202 
F96 0.000676 1.09E-05 0.02408 0.000535 0.82 0.0176 
N97 0.000668 6.1E-06 0.022868 0.00056 0.86 0.012 
L98 0.00072 1.46E-05 0.023751 0.000216 0.89 0.0195 
Y99 0.000741 1.02E-05 0.022918 0.00059 0.8 0.0174 
Y100 0.000735 1.92E-05 0.021304 0.000416 0.86 0.0145 
Y101 0.000735 6.7E-06 0.023294 0.000519 0.77 0.0158 
E102 0.000725 1.34E-05 0.02955 0.000339 0.8 0.0202 
S103 0.00071 8.2E-06 0.030225 0.000374 0.87 0.0244 
D104 0.000704 0.000005 0.024055 0.000541 0.85 0.0551 





F110 0.000865 1.28E-05 0.02268 0.000393 0.59 0.0158 
I111 0.000717 1.11E-05 0.024061 0.000462 0.8 0.0215 
R112 0.000712 9.2E-06 0.0234 0.000551 0.73 0.0143 
E113 0.00069 8.9E-06 0.020039 0.000363 0.67 0.023 
N114 0.00084 3.18E-05 0.025278 0.000798 0.59 0.0193 
Q115 
F116 
V117 0.000679 0.00001 0.021042 0.000513 0.82 0.0224 
K118 0.000721 1.28E-05 0.020916 0.000743 0.8 0.0227 
I119 0.000713 1.08E-05 0.022499 0.000628 0.77 0.02 
D120 
T121 0.00064 9.2E-06 0.022733 0.000691 0.8 0.0164 
I122 0.000662 1.34E-05 0.023767 0.000491 0.79 0.0151 
A123 0.000637 7.8E-06 0.02418 0.000392 0.78 0.0124 
A124 0.000652 8.2E-06 0.021178 0.000518 0.7 0.0193 
D125 
E126 
S127 0.000886 9.2E-06 0.016379 0.000425 0.61 0.0293 
F128 0.001108 1.06E-05 0.013284 0.006522 0.6 0.0182 





D132 0.000918 8.3E-06 0.027361 0.000376 0.52 0.0141 
I133 0.000969 1.07E-05 0.024917 0.00031 0.49 0.0114 
G134 0.001131 2.63E-05 0.036838 0.000223 0.56 0.016 
D135 0.000991 1.68E-05 0.015397 0.00055 0.59 0.0231 
R136 0.000834 8.8E-06 0.018099 0.000373 0.5 0.0137 
I137 
M138 
K139 0.000646 7.9E-06 0.020376 0.000511 0.64 0.0206 
L140 0.00083 0.000009 0.01907 0.000378 0.61 0.0184 
N141 0.000678 6.1E-06 0.030244 0.000583 0.8 0.0165 
T142 0.000661 9.9E-06 0.019453 0.000357 0.77 0.0184 
E143 0.000697 0.000005 0.020829 0.000402 0.79 0.0166 
I144 0.000687 1.37E-05 0.019951 0.000484 0.81 0.0154 
R145 0.000716 1.06E-05 0.021028 0.000464 0.8 0.017 
D146 0.000643 5.7E-06 0.019333 0.000501 0.8 0.0192 
V147 0.000719 4.6E-06 0.021316 0.000379 0.78 0.0178 
G148 0.000679 8.8E-06 0.020392 0.000362 0.72 0.0477 
P149 




G154 0.000731 2.01E-05 0.023299 0.000776 0.78 0.0161 
F155 0.000762 0.000011 0.021894 0.00039 0.84 0.0204 
Y156 
L157 0.00074 1.08E-05 0.023025 0.000539 0.85 0.0161 
A158 0.000698 1.06E-05 0.021919 0.000565 0.82 0.0259 
F159 0.000665 1.39E-05 0.020162 0.00046 0.83 0.0174 
Q160 0.000675 1.05E-05 0.022111 0.000479 0.82 0.0169 
D161 0.000746 1.18E-05 0.022873 0.000508 0.79 0.0132 
V162 0.00053 1.66E-05 0.017221 0.004649 0.79 0.0198 
G163 0.000686 4.3E-06 0.02317 0.000427 0.81 0.0123 
A164 0.000701 8.1E-06 0.023987 0.000336 0.8 0.0147 
C165 0.00067 1.26E-05 0.020842 0.000358 0.79 0.0191 
I166 
A167 0.000744 9.7E-06 0.022756 0.000297 0.81 0.0147 
L168 0.00066 7.9E-06 0.022074 0.000441 0.83 0.0246 
V169 0.000851 2.13E-05 0.018397 0.000476 0.6 0.0207 
S170 0.000794 1.22E-05 0.021749 0.000293 0.86 0.0166 
V171 0.000758 9.5E-06 0.02049 0.000462 0.81 0.0112 
R172 0.000725 1.28E-05 0.022262 0.000493 0.81 0.0164 
V173 0.000716 0.000012 0.021905 0.000251 0.81 0.0137 
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F174 0.000755 1.07E-05 0.023005 0.000446 0.86 0.0138 
Y175 0.000747 7.6E-06 0.021668 0.00048 0.87 0.0134 
K176 0.000708 1.39E-05 0.019809 0.000293 0.75 0.0163 
 
Table 3.10: Modelfree analysis results of EphA4 LBD 
Residue S2 S2 error τe τe error Rex Rex error Sf2 Sf2 error model χ2 
G1     
S2     
N3.     
E4.     
V5 0.82625 0.028509 0.83962 0.13488 0 0 1 0 1 5.9682 
T6 0.86266 0.010435 0.011161 0.003741 2.8438 0.53403 1 0 3 5.61E-09 
L7 0.88486 0.008609 0.016403 0.003585 4.5202 0.69208 1 0 3 1.17E-09 
L8 0.84618 0.008758 0.0081 0.002416 2.9319 0.63539 1 0 3 3.90E-08 
D9 0.96266 0.013088 0 0 1.0599 0.36976 1 0 2 0.25557 
S10 0.97236 0.01458 0.1123 0.090479 0 0 1 0 1 1.5709 
R11     
S12 0.88928 0.015442 0.82584 0.094815 0 0 0.94918 0.012345 4 5.27E-07 
V13 0.9056 0.026513 0.44584 0.14227 0 0 1 0 1 6.1935 
Q14     
G15     
E16 0.85851 0.009792 0.3029 0.039194 0 0 1 0 1 0.92318 
L17 0.70504 0.007892 0.010021 0.000795 0 0 1 0 1 0.20825 
G18 0.91611 0.002771 0.59446 0.018815 0 0 1 0 1 0.13388 
W19 0.84552 0.025637 0.95906 0.080242 0 0 0.94713 0.020016 4 5.89E-07 
I20 0.84124 0.01452 0.03921 0.00492 2.9551 0.38373 1 0 3 6.01E-08 
A21     
S22 0.86755 0.019906 0 0 6.5742 0.68674 1 0 2 0.98689 
P23     
L24 0.96411 0.049274 0 0 1.6889 1.4824 1 0 2 7.02E+00 
E25 0.89426 0.023811 0.062015 0.019155 0 0 1 0 1 2.66E+00 
G26 0.89612 0.028636 0.046374 0.0183 0 0 1 0 1 4.33E+00 
G27 0.8946 0.010574 0.035089 0.005354 1.8644 0.39327 1 0 3 4.84E-09 
W28 0.98548 0.052053 0 0 0.97858 1.8217 1 0 2 5.4756 
E29 0.93125 0.008797 0.028657 0.007785 2.1418 0.48923 1 0 3 3.37E-08 
E30 0.88392 0.010315 0.028976 0.004923 3.8852 0.45679 1 0 3 5.28E-09 
V31 0.90838 0.016501 0.033823 0.010266 4.5083 0.48555 1 0 3 1.25E-08 
S32     
I33 0.87911 0.01309 0.02746 0.004493 5.1792 0.57426 1 0 3 1.35E-08 
M34 0.86546 0.014388 0.03731 0.00615 4.4535 0.41499 1 0 3 1.66E-08 
D35 0.89232 0.018912 0.64932 0.1056 0 0 1 0 1 3.34E+00 
E36 0.78846 0.026162 0.85936 0.070987 0 0 0.94305 0.019941 4 7.34E-06 
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K37     
N38 0.85634 0.019535 0.77051 0.099185 0 0 0.91999 0.015255 4 4.20E-07 
T39 0.9144 0.017239 0.56409 0.27693 0 0 0.94601 0.013877 4 1.09E-07 
P40     
I41 0.90388 0.010458 0.060749 0.009259 2.7461 0.53569 1 0 3 2.99E-08 
R42 0.7945 0.016333 0.014795 0.002385 7.5169 0.67689 1 0 3 1.32E-08 
T43 0.94197 0.012036 0.046051 0.014714 2.957 0.55739 1 0 3 3.98E-09 
Y44 0.96674 0.021099 0 0 2.0128 0.80338 1 0 2 1.2823 
Q45 0.95547 0.029795 0 0 0 0 1 0 0 7.855 
V46 0.90622 0.020396 0 0 3.8169 1.0229 1 0 2 1.57E+00 
C47 0.87842 0.055019 0 0 5.1034 2.0727 1 0 2 6.0101 
N48 0.80755 0.043112 0 0 6.3004 2.3687 1 0 2 4.07E+00 
V49 0.96194 0.005443 0.27493 0.090494 1.4695 0.36343 1 0 3 3.41E-09 
M50     
E51     
P52     
S53 0.81646 0.021474 0.46554 0.060948 0 0 0.90803 0.015153 4 6.25E-07 
Q54 0.91281 0.01783 0.066005 0.018455 0 0 1 0 1 2.39E+00 
N55 0.90151 0.016543 0.012955 0.004524 2.3213 0.5587 1 0 3 6.59E-09 
N56 0.92102 0.021973 0 0 0 0 1 0 0 7.438 
W57 0.8811 0.029742 0 0 6.0227 0.68009 1 0 2 2.1405 
L58 0.73744 0.00995 0.006689 0.001835 3.2887 0.43411 1 0 3 3.91E-08 
R59 0.77225 0.013584 0.009256 0.001984 6.2916 0.37487 1 0 3 4.09E-08 
T60 0.95797 0.025547 0 0 0 0 1 0 0 7.28E+00 
D61     
W62     
I63     
T64     
R65 0.87241 0.019258 0.023851 0.006669 1.6936 0.54061 1 0 3 8.32E-09 
E66 0.83881 0.014183 0.63695 0.052238 0 0 1 0 1 1.56E+00 
G67 0.95522 0.007822 0.47901 0.1044 2.9377 0.60645 1 0 3 1.70E-09 
A68     
Q69     
R70 0.80893 0.010834 0.023864 0.002816 4.6835 0.51785 1 0 3 2.51E-08 
V71 0.9364 0.024207 0 0 3.1194 1.0312 1 0 2 8.98E-01 
Y72 0.91083 0.009952 0 0 2.595 0.39818 1 0 2 0.27627 
I73 0.90797 0.025091 0 0 0 0 1 0 0 11.074 
E74 0.89671 0.012665 0.015681 0.004125 3.4656 0.40844 1 0 3 8.03E-09 
I75 0.93046 0.021306 0 0 2.65 0.88734 1 0 2 1.0489 
K76 0.91194 0.020948 0 0 3.2835 0.95597 1 0 2 1.1845 
F77 0.94321 0.023751 0 0 3.7667 1.4086 1 0 2 1.5911 
T78 0.98115 0.022462 0 0 2.8945 0.6011 1 0 2 0.48748 
L79     
R80 0.91744 0.009739 0.051355 0.008231 2.2778 0.59966 1 0 3 5.16E-08 
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D81 0.94156 0.009146 0.46179 0.079331 0 0 1 0 1 1.3736 
C82 0.97064 0.008418 0.38528 0.19173 3.9369 0.51657 1 0 3 7.48E-09 
N83 0.95282 0.008317 0.2668 0.1149 3.2566 0.49025 1 0 3 1.48E-08 
S84 0.92708 0.012869 0.46906 0.10666 0 0 1 0 1 8.52E-01 
L85 0.89739 0.00864 0.67816 0.054505 0 0 1 0 1 0.73315 
P86     
G87     
V88 0.7059 0.021881 0.89293 0.035437 0 0 0.9299 0.01726 4 7.38E-06 
M89     
G90     
T91 0.63842 0.08765 0.96952 0.14306 0 0 0.89499 0.14219 4 6.57E-08 
C92 0.86615 0.010809 0.64276 0.047222 0 0 1 0 1 1.091 
K93 0.96682 0.008411 0.16228 0.11134 4.1635 0.5401 1 0 3 9.66E-09 
E94 0.85187 0.01735 0.6843 0.10913 0 0 0.9082 0.013357 4 4.46E-07 
T95 0.79931 0.010939 0.012779 0.002526 8.6239 0.41107 1 0 3 3.03E-07 
F96 0.85534 0.043095 0 0 7.1763 1.8604 1 0 2 4.2988 
N97 0.86235 0.003299 0 0 5.4494 0.24231 1 0 2 0.078673 
L98 0.95026 0.049303 0 0 4.1065 1.1519 1 0 2 2.9034 
Y99 0.97732 0.02712 0.66478 0.82157 0 0 1 0 1 7.29E+00 
Y100 0.99859 0.006959 0 0 0 0 1 0 0 0.39886 
Y101 0.95679 0.009153 0.064658 0.020738 3.423 0.55119 1 0 3 3.42E-08 
E102 0.9725 0.075627 0 0 9.151 2.1369 1 0 2 7.9378 
S103 0.90087 0.008639 0 0 12.392 0.34884 1 0 2 0.30473 
D104 0.91951 0.001208 0 0 5.3305 0.10206 1 0 2 1.50E-02 
N105 0.90463 0.011962 0.017111 0.004631 3.0111 0.57583 1 0 3 2.30E-08 
D106     
K107     
E108     
R109     
F110 0.86773 0.00888 0.62316 0.037652 4.4702 0.41888 1 0 3 9.57E-09 
I111 0.97271 0.007751 0.72522 0.28209 2.0106 0.48978 1 0 3 1.56E-08 
R112 0.96752 0.005271 0.25771 0.11013 1.9117 0.60599 1 0 3 1.50E-08 
E113 0.8393 0.011411 0.033123 0.003982 3.306 0.40882 1 0 3 1.71E-08 
N114 0.89653 0.01884 0.47287 0.12479 7.1334 0.87516 1 0 3 8.10E-09 
Q115     
F116     
V117 0.8625 0.031223 0 0 3.8939 1.3943 1 0 2 2.66E+00 
K118 0.97128 0.010346 0.060763 0.027332 0 0 1 0 1 1.94E-01 
I119 0.97923 0.01256 0.21291 0.53714 0 0 1 0 1 2.53E+00 
D120     
T121 0.86012 0.012558 0.010576 0.003014 4.3983 0.75747 1 0 3 4.45E-09 
I122 0.82666 0.017254 0.010298 0.002357 7.362 0.61042 1 0 3 6.18E-09 
A123 0.82307 0.010193 0.011204 0.001813 7.2519 0.44216 1 0 3 2.67E-08 
A124 0.79136 0.010436 0.01994 0.002542 5.5506 0.56475 1 0 3 1.77E-09 
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D125     
E126     
S127 0.68812 0.018883 1.004 0.075588 0 0 0.89483 0.016243 4 5.16E-07 
F128 0.61639 0.08323 1.1083 0.14888 0 0 0.91465 0.13342 4 4.38E-08 
T129 0.84613 0.000918 0.81071 0.004449 0 0 1 0 1 5.76E-03 
Q130     
V131     
D132 0.82665 0.006998 0.60905 0.020703 10.566 0.39314 1 0 3 9.48E-09 
I133 0.77191 0.008169 0.70515 0.018693 8.4515 0.34145 1 0 3 1.06E-07 
G134     
D135 0.78095 0.040312 0.85263 0.14591 0 0 1 0 1 5.31E+00 
R136 0.88488 0.011647 0.35204 0.057898 0 0 1 0 1 1.386 
I137     
M138     
K139 0.77025 0.010179 0.024934 0.00235 5.1873 0.58971 1 0 3 1.11E-08 
L140 0.90766 0.016974 0.47751 0.10187 0 0 1 0 1 2.57E+00 
N141 0.83646 0.008132 0.009469 0.002409 13.888 0.57675 1 0 3 8.65E-09 
T142 0.84205 0.013293 0.014729 0.003047 2.2453 0.47573 1 0 3 3.27E-08 
E143 0.89023 0.007274 0.017228 0.003903 2.7149 0.47188 1 0 3 1.64E-08 
I144 0.92414 0.041258 0 0 0 0 1 0 0 1.68E+01 
R145 0.92987 0.014353 0.023707 0.008923 1.8283 0.55395 1 0 3 1.00E-08 
D146 0.83152 0.00833 0.008771 0.002363 2.2503 0.54698 1 0 3 6.97E-09 
V147 0.90575 0.007054 0.023891 0.005004 3.1097 0.40973 1 0 3 9.40E-09 
G148 0.8238 0.014296 0.02147 0.006532 4.2205 0.45274 1 0 3 1.02E-08 
P149     
L150 0.5881 0.06951 0.84562 0.10992 0 0 0.93047 0.12252 4 2.12E-08 
S151     
K152   0 0 0 1 43.242 
K153     
G154 0.95398 0.021698 0.052013 0.14572 3.4949 0.92045 1 0 3 3.38E-09 
F155     
Y156     
L157 0.9894 0.009176 0 0 2.3618 0.39307 1 0 2 0.18361 
A158 0.91298 0.029601 0 0 3.2142 1.3289 1 0 2 2.01E+00 
F159 0.85978 0.019071 0.005117 0.002026 2.6322 0.62154 1 0 3 1.10E-08 
Q160 0.86723 0.043452 0 0 4.6738 1.7784 1 0 2 4.69E+00 
D161 0.95254 0.014636 0.043986 0.041151 3.4554 0.55721 1 0 3 3.44E-09 
V162 0.67617 0.051164 0 0 0 0 1 0 0 1.19E+01 
G163 0.86121 0.006121 0.009314 0.002158 6.067 0.43884 1 0 3 7.31E-08 
A164 0.95602 0.01132 0.037871 0.016668 3.3313 0.40789 1 0 3 3.52E-08 
C165 0.85621 0.016105 0.012595 0.003561 3.3761 0.46122 1 0 3 1.23E-08 
I166     
A167 0.95948 0.059148 0 0 3.3542 1.8357 1 0 2 10.053 
L168 0.84091 0.016142 0 0 5.3143 0.78005 1 0 2 1.16E+00 
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V169 0.86622 0.010558 0.65748 0.048176 0 0 1 0 1 3.21E-01 
S170     
V171 0.98741 0.000109 0.22031 0.012016 0 0 1 0 1 0.00058 
R172 0.9319 0.017103 0.020249 0.009528 3.2486 0.58878 1 0 3 1.17E-08 
V173 0.9329 0.015045 0.020349 0.008336 2.6245 0.39565 1 0 3 2.81E-08 
F174 0.97678 0.005069 0 0 3.2018 0.192 1 0 2 0.059311 
Y175 0.97377 0.014547 0 0 1.8074 0.74914 1 0 2 0.98451 








































4.1   Summary     
My thesis is composed of two sections: Structural and interaction study of Nogo-A 
and structural and interaction study of EphA4 receptor and its ephrin ligands, small 
molecule antagonists, as well as dynamics study to free EphA4. 
Nogo-A has been proposed to play key roles in a variety of important biological 
processes. More recently, a change in Nogo-A level has been observed in several 
neural diseases such as stroke, Alzheimers’ and Amyotrophic lateral sclerosis (ALS). 
However, the mechanism regulating Nogo-A levels in cells remains unknown. By 
using T7 phage display, our collaborators identified an E3 ubiquitin ligase WWP1, 
which can interact with Nogo-A. Further study implied that the interaction may 
trigger the ubiquitination and degradation of Nogo-A. In the present work, we gave a 
detailed picture on how WWP1 interacts with Nogo-A proline rich domain. 
 Eph/ephrin comprises the largest protein kinase family. The bidirectional signaling 
pathways initiated by their interaction are involved in various bioprocesses. EphA4 
receptor attracts intensive study not only for its important role in function mediation, 
but also for its ability to bind both ephrin ligands types. However, there is still limited 
structure information on this receptor and its complexes. This thesis therefore gave 
substantial research on EphA4 ligand binding domain structure, the structures of 
EphA4 complexes with ephrin ligands, small organic antagonists, as well as its 
dynamics study by NMR. 
 
4.2   Key contributions 
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WWP1 interact with Nogo-A through interaction between WW domains and 
PPxY motif 
WWP1 and its isolated 4 WW domains bind with Nogo-A proline rich motif with a 
Kd of micro molar range. NMR structure of WW4 domain was resolved, and its 
complex model with Nogo-A peptide was derived by molecular docking. For the first 
time, we present the evidence that WWP1 is a novel interacting partner of Nogo-A. 
Following ubiquitination and protein degradation maybe one of the important 
mechanisms in regulating Nogo-A levels and functions in disease states. Our study 
provides rationales as well as template for further design of molecule to intervene in 
the WWP1-Nogo-A interaction and further regulate Nogo-A protein level by 
controlling its ubiqutination.  
16 EphA4 LBD crystal structures show highly dynamic loops and dramatic 
conformational exchange of J-K loop 
16 structures of EphA4 ligand binding domain from two protein crystals were 
resolved with resolution of 2.4Å and 2.9Å. These crystals were special because one 
asymmetric unit contained 8 molecules, which has never been observed in previous 
works. This observation enabled us to capture the images of 16 EphA4 molecules at 
the same time. Strikingly, 16 EphA4 structures are almost identical over the 
secondary structure regions but show high variations over the D-E, G-H and J-K loops. 
Based on this result, it is likely that, even for the free EphA4 ligand domain, many 
different conformations coexist over the loop regions, which may be ready for binding 
to different ligands with slight rearrangements. In addition, through the careful 
analysis to loop conformation and contact between molecules, we found that the 
transition from closed state to open state needs interaction from other molecule. 
Otherwise, the molecule will prefer closed state with flexibility at certain degree. 
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Based on our results, the interaction between Eph receptors and ephrin ligands seems 
to follow induce-fit mechanism. How does the external interaction help the transition 
of J-K loop from closed to open conformation is still under investigation. Due to the 
poor resolution of protein crystals, electron density map of some residues of several 
critical loops were missed or only backbone could be traced, but those missed map 
will not affect our conclusion because those visible residues have given enough 
electron density map to define the loop conformations. In addition, the residues on J-
K loop defining open or closed states are from A121 to S126, and this fragment is 
absent in only two structures among these 16 structures, and the rest 14 structures 
show clearly which state the structure adopts. These results also suggest how 
important protein dynamics is in understanding protein-protein interaction and it 
could be interesting to investigate further in future. 
A newly discovered interaction surface by crystal structure of EphA4/ephrinB2 
A very interesting phenomenon of interaction between Eph receptors and ephrins 
ligands is that Eph receptors interact promiscuously with ephrins of the same class. 
They rarely interact with ephrins of the other class. However, EphA4 can bind all 
ephrin-A and B ligands. The distinctive ability of EphA4 makes it an attractive model 
to understand the structural principles underlying the selectivity versus promiscuity of 
Eph receptor-ephrin interactions. In our study, we presented the first EphA4-ephrin 
complex structure and identified a polar contact region structurally separated from the 
ephrin-binding channel, which is critical for EphA4-ephrin-B2 binding. The results 
showed that EphA4 uses different strategies for binding ephrin-A versus ephrin-B 
ligands, thus achieving remarkable promiscuity. We also characterized the EphA4-
ephrin-B2 complex in solution by NMR spectroscopy, which represents the first NMR 
visualization of an Eph-ephrin complex. These findings contribute to our 
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understanding of the distinctive binding determinants that characterize selectivity 
versus promiscuity of Eph receptor-ephrin interactions and suggest that diverse 
strategies may be needed to design antagonists for effectively disrupting different 
Eph-ephrin complexes. 
First picture on the structure study of EphA4 ligand binding domain complex 
with small molecule antagonist  
Due to the critical role in wide function spectrum, Eph receptors and ephrins 
ligands, have become a very important target for drug design. The high affinity 
binding pocket of Eph receptors is a very attractive target for designing of small 
molecule antagonist to block ephrins ligand binding. In my thesis, we presented the 
first small molecule antagonists that can inhibit EphA4 and EphA2, and gained 
structure insight into the binding interaction between small molecules and EphA4. 
Our study gave solid evidence to confirm that these compounds indeed bind to the 
classical binding pocket of EphA4 ligand binding domain. The molecular docking 
models provided a structural rational for the results of an extensive structure-activity 
study on a large set of small molecules with a pyrrolyl benzene scaffold and for the 
high binding selectivity but relatively weak affinity of the compounds. Based on our 
results, to optimize the small antagonists to achieve higher affinity and specificity will 
be an interesting direction to go. 
First NMR solution structure of EphA4 LBD and dynamics study to free EphA4 LBD 
X-ray crystallography has become the most important tool in determining the 
protein structure, but the packing force during crystallization will quench the local 
motion of protein. NMR spectroscopy is capable of providing solution structure and 
dynamics information of protein, further reveals the structure function relationship. In 
this study, we resolved the first NMR solution structure of Eph receptors. This 
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structure shows that the loops of EphA4 are highly dynamic, especially functional 
related D-E and J-K loops. This results also explained why D-E and J-K loops 
adopted different orientation in different X-ray structure. Further dynamics study of 
free EphA4 LBD shows that the loops are highly flexible and have dramatic 
conformational exchange on µs-ms time scale. This property could be important for 
EphA4 LBD in the transition from closed to open state. While the regions with 
secondary structure are rigid in both ps-ns but show minor conformational exchange 
on µs-ms time scales. In another word, the whole molecule of EphA4 LBD undergoes 
minor conformational exchange on µs-ms time scales, which is probably important 
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